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SUMMARY 
 
Mitochondria ATP-sensitive potassium channels (mitoKATP) were first described in 1991 by 
direct patch clamp of isolated mitoplasts (i.e. mitochondria lacking the outer membrane). 
Since then, a growing amount of evidences showed that they are implicated in the control of 
a variety of mitochondrial functions. Most importantly, pharmacological modulation of the 
mitoKATP can efficiently protect the heart from ischemia/reperfusion injury. However, 
despite its huge therapeutic potential, the molecular identity of the mitoKATP is still 
unknown. Here we identify a protein complex that is sufficient to reconstitute a functional K+ 
permeant channel with the same pharmacological profile of the mitoKATP. In particular, we 
demonstrate that the mitoKATP is a heterooligomer composed by two different components. 
One is a previously uncharacterized protein of unknown function that we now name “mitoK” 
(formerly known as coiled-coil domain containing protein 51, CCDC51). The other is a protein 
belonging to the ABC superfamily (formerly known as ABCB8) here named “mitoSUR”. It 
possesses a nucleotide-binding site (a standard Walker motif) and provides ATP sensitivity to 
the mitoK pore-forming subunit through direct protein interaction.  
In detail, we demonstrated that mitoK is a mitochondrial protein located in the inner 
mitochondrial membrane (IMM), with two transmembrane domains and both its N- and C-
termini exposed to the organelle matrix. Its overexpression induces a decrease in 
mitochondrial Ca2+ transients evoked by agonist stimulation, a drastic reduction of 
mitochondria membrane potential, fragmentation of the mitochondrial network and a 
derangement of the IMM ultrastructure, with the total collapse of the cristae. However, all 
these effect can be rescued by the concomitant overexpression of mitoSUR, but not by the 
expression of the mitoSURK513A mutant that lacks ATP binding. Most importantly, in vitro 
reconstitution of purified mitoK and mitoSUR in a planar lipid bilayer form a channel i) 
selective for monovalent cations, ii) blocked by tetraethyl ammonium (TEA, a general 
inhibitor of K+ channels), iii) sensitive to ATP, iv) activated by diazoxide and v) inhibited by 5-
HD. 
Finally, we focused our efforts to understand the physiological role of mitoKATP. According to 
the available literature, mitoKATP channels are believed to be protective in 
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ischemia/reperfusion injury. However, the broad conservation profile among all vertebrates 
suggests that the mitoKATP should also have a primary housekeeping function. In order to 
analyze the genuine physiological role of the mitoKATP, we generated Hela cells knockout for 
mitoK by using the Crispr/Cas9 technology. Two different guides targeting different gene 
regions were validated and several Hela mitoKKO clones were obtained. Overall, ablation of 
mitoK leads to no gross defects in mitochondria morphology, although an impairment of 
cristae structure becomes evident through electron microscopy. Mitochondrial membrane 
potential is overall intact and expression of respiratory chain complexes is unaffected. 
However, we noticed that Hela mitoKKO cells undergo to asynchronous, rapid and transient 
depolarizations of single mitochondria, a phenome known as “flickering” of mitochondria 
membrane potential. Therefore, oxygen consumption rate (OCR) is greatly impaired in Hela 
mitoKKO cells when compared to their wild type counterparts, in both basal, leaky 
(oligomycin induced) and maximal (i.e. FCCP induced) respiration. As already reported, 
mitochondrial K+ homeostasis is fundamental to regulate mitochondrial matrix volume: 
while excessive accumulation leads to organelle swelling, a decrease in K+ uptake is 
predicted to cause matrix contraction, with obvious consequences on the performance of 
the oxidative phosphorylation. Overall, our data indicates that mitoKATP is a central regulator 
of mitochondrial function that modulates the efficiency of energy production according to 
the ATP availability through the regulation of matrix volume. 
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RIASSUNTO 
 
I canali mitocondriali del potassio sensibili all’ATP (mitoKATP) sono stati descritti per la prima 
volta nel 1991 in seguito ad esperimento di patch clamp su mitoplasti (mitocondri privi della 
membrana mitocondriale esterna) isolati. Da allora, un numero crescente di esperimenti ha 
dimostrato il coinvolgimento di questi canali nella regolazione di numerose funzioni 
mitocondriali. In particolare, la modulazione farmacologia di questi canali può efficacemente 
proteggere il cuore dal danno da ischemia/riperfusione. Tuttavia, nonostante il loro enorme 
potenziale terapeutico, la struttura molecolare dei canali mitoKATP è ancora oggi sconosciuta. 
In questo lavoro abbiamo identificato un complesso proteico permeabile al K+ con lo stesso 
profilo farmacologico dei canali mitoKATP. In particolare, abbiamo dimostrato come  questi 
canali siano composti da due differenti subunità. Una di queste è una proteina non ancora 
caratterizzata dal punto di vista biologico e con funzione sconosciuta, che d’ora in poi 
chiameremo “mitoK” (precedentemente nota come CCDC51). L’altra componente del canale 
è una proteina appartenente alla superfamiglia delle proteine ABC (precedentemente nota 
come ABCB8), che chiameremo “mitoSUR”. Quest’ultima possiede un dominio in grado di 
legare ATP (chiamato “dominio Walker”) attraverso cui fornisce sensibilità ai canali mitoKATP 
attraverso una interazione diretta con mitoK. 
In particolare, abbiamo dimostrato che mitoK è una proteina mitocondriale sita sulla 
membrana mitocondriale interna, con due domini transmembrana e le rispettive porzioni N- 
e C- terminale esposte nella matrice. La sovraespressione di mitoK induce una diminuzione 
dell’accumulo mitocondriale dello ione calcio in risposta a stimoli, una drastica riduzione del 
potenziale di membrana mitocondriale, frammentazione della  morfologia mitocondriale ed 
una perdita totale delle cristae. Tuttavia, le normali funzioni mitocondriali possono essere 
recuperate attraverso la contemporanea sovraespressione di mitoSUR, ma non 
dall’espressione del mutante mitoSURK513A mancante del dominio che lega ATP. Inoltre, 
l’espressione in vitro delle proteine purificate mitoK e mitoSUR ed il loro inserimento in una 
membrana artificiale ci ha permesso di studiarne le caratteristiche elettrofisiologiche, 
dimostrando che mitoK e mitoSUR formano un canale i) selettivo per cationi monovalenti, ii) 
inibito da ammonio tetraetile (TEA, un inibitore generico per i canali K+), iii) sensibile ad ATP, 
iv) attivato da diazossido e v) inibito da 5-HD.  
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Infine abbiamo cercato di comprendere il ruolo fisiologico dei canali mitoKATP. Secondo la 
letteratura disponibile, questi canali hanno un ruolo protettivo nel danno da 
ischemia/riperfusione. Tuttavia, l’ampio profilo di conservazione tra tutti i vertebrati 
suggerisce che i canali mitoKATP abbiano prima di tutto un ruolo nel controllo delle normali 
funzioni mitocondriali. Al fine di analizzare il vero e proprio ruolo fisiologico di questi canali 
mitoKATP, abbiamo generato cellule Hela prive del gene che codifica per mitoK utilizzando la 
tecnologia Crispr/Cas9. Utilizzando due differenti guide in grado di riconoscere due diverse 
regioni del gene sono stati ottenuti alcuni cloni cellulari privi di mitoK a livello proteico. Nel 
complesso, la mancanza di mitoK non comporta alcun difetto in termini di morfologia 
mitocondriale, anche se è evidente una diversa strutture delle cristae attraverso la 
microscopia elettronica. Il potenziale di membrana mitocondriale è complessivamente 
intatto e l’espressione dei complessi della catena respiratoria è inalterata. Tuttavia, abbiamo 
notato che le cellule Hela mitoKKO vanno incontro a depolarizzazioni asincrone, rapide e 
transitorie, caratteristiche di un fenomeno conosciuto come “flickering” del potenziale di 
membrana mitocondriale. Abbiamo inoltre osservato che il consumo di ossigeno (OCR) è 
notevolmente ridotto in questi cloni rispetto alle cellule di controllo, sia in termini di 
respirazione basale che massimale. Dalla letteratura è infatti noto che l’omeostasi 
mitocondriale del potassio è fondamentale per regolare il volume della matrice 
mitocondriale; mentre un accumulo eccesivo di K+ comporta un aumento del volume, una 
diminuzione dell’accumulo di K+ può causare la contrazione della matrice, con ovvie 
conseguenze sulle prestazioni della fosforilazione ossidativa. Nel complesso, i nostri dati 
indicano che i canali mitoKATP regolano le funzioni mitocondriali, modulando l’efficienza della 
produzione di energia secondo la disponibilità di ATP attraverso la regolazione del volume 
della matrice. 
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INTRODUCTION 
MITOCHONDRIA 
The general framework  
 
Mitochondria are dynamic organelles that are involved in a number of essential cellular 
processes. They play an important role in energy metabolism as the majority of the cellular 
ATP is generated via oxidative phosphorylation. In addition, mitochondria are the major 
source of reactive oxygen species (ROS), which play pivotal roles in signaling and cell injury. 
In higher eukaryotes mitochondria play a major role in the regulation of apoptosis. Based on 
these vital processes, many human diseases are linked to mitochondrial dysfunctions, 
including neurodegenerative diseases (Alzheimer’s, Parkinson’s, Hungtinton’s), motoneuron 
disorders (amyotrophic lateral sclerosis, type 2A Charcot-Marie-Tooth neuropathy), 
autosomal dominant optic atrophy, ischemia-reperfusion injury, diabetes, ageing and cancer 
(Duarte et al., 2014; Gaude and Frezza, 2014). In addition, mutations in mitochondrial DNA 
cause a variety of pathologies, including MELAS (Mitochondrial Encephalopathy and Lactic 
Acidosis with Stroke like episodes) or Leigh’s syndrome (Wallace D.C., 2005).  
From a structural point of view, mitochondria are composed by two functionally different 
membranes: the plain outer membrane (OMM), contains high copy number of a specific 
channel, the Voltage Dependent Anion Channel (VDAC), which is able to forms pores on the 
membrane, becoming mostly permeable to ions and metabolites up to 5000 Da; the highly 
selective inner membrane (IMM), characterized by invaginations called cristae which enclose 
the mitochondria matrix. IMM is characterized by the presence of cardiolipin. In addition, on 
the IMM is it possible to find also other specific transport proteins. The space between the 
two membranes is called intermembrane space (IMS). The cristae define internal 
compartments formed by profound invaginations originating from narrow tubular structures 
called cristae junctions (Mannella et al., 2006) that limit the diffusion of molecules from the 
intra-cristae space towards the IMS, thus creating a micro-environment where the 
mitochondrial Electron Transport Chain (mETC) complexes are hosted and other proteins are 
protected from random diffusion. mETC consists of five different protein complexes: 
complex I (NADH dehydrogenase), complex II (succinate dehydrogenase), complex III 
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(ubiquinol cytochrome c reductase), complex IV (cytochrome c oxidase) and complex V that 
constitutes the F1F0-ATP synthase. Electrons are transferred from NADH and FADH2 through 
these complexes to molecular oxygen: as electrons move along the respiratory chain, energy 
is stored as an electrochemical gradient across the inner membrane, thus creating a negative 
mitochondrial membrane potential (that is around -180mV against the cytosol). H+ are 
forced to re-enter into the matrix mainly through complex V, which couples this proton 
driving force to the phosphorylation of ADP into ATP, according to the chemiosmotic theory. 
ATP is then released to IMS through the electrogenic Adenine Nucleotide Translocase (ANT), 
which exchanges ATP with ADP to provide new substrate for ATP synthesis. Finally, ATP can 
easily escape the IMS thanks to the mitochondrial porin of the outer mitochondrial 
membrane VDAC (Duchen, 2004). 
Mitochondrial Ca2+ signaling 
 
Mitochondria are important modulators of the amplitude and duration of Ca2+ signaling; 
they are able to accumulate a large amount of Ca2+ thanks to the electrochemical gradient 
established by the translocation of protons across the inner mitochondrial membrane 
(IMM), which is expressed as a membrane potential difference (ΔΨm) of -180mV (negative 
inside) under physiological conditions (Mitchell, 1966). However, in resting conditions the 
mitochondrial calcium concentration is very low, comparable to the cytosolic one. In 
addition, experiments carried out in isolated mitochondria revealed that organelle Ca2+ 
transport has an apparent low affinity for this cation, that activates only at 
supraphysiological extramitochondrial [Ca2+]. Thus, the role of mitochondria in Ca2+ 
homeostasis was considered marginal (i.e. limited to conditions of cellular Ca2+ overload), till 
the development of specific and reliable probes that directly reported major swings of 
mitochondrial [Ca2+] even upon physiological stimuli (Rizzuto et al., 1992). The generation of 
photoprotein aequorin probe targeted to mitochondria allowed to demonstrate that in living 
and intact Hela cells the transient increase of [Ca2+]cyt to 1-3µM, induced by physiological 
stimuli, is always associated with a parallel increase in [Ca2+] in mitochondrial matrix which 
in most of cells reaches about 60-80 µM. It was thus clear that mitochondria play an active 
role in Ca2+ signaling. However, the chemiosmotic theory is not sufficient to explain the 
ability of energized mitochondria to rapid accumulate a large amount of Ca2+: a lot of 
12 
 
experiments in isolated mitochondria have demonstrated that the systems of mitochondrial 
calcium accumulation are low affinity, they are activated when the [Ca2+]cyt reaches value in 
order of 5-10µM, which rarely happens in physiological conditions. This discrepancy was 
resolved by the demonstration that the key of the rapid Ca2+mit accumulation resides in the 
strategic location of mitochondria in close proximity to ER-resident Ca2+ channels and implies 
the assembly of a dedicated signaling unit at the interface of the two organelles. By labelling 
mitochondria and ER with targeted spectral variants of GFP (mtGFP and erGFP) the presence 
of overlapping regions of the two organelles, called “ER/mitochondria contact sites” has 
been revealed and the area of the contact sites has been estimated as 5-20% of the total 
mitochondrial surface (Rizzuto et al., 1998). In this way mitochondria are located in close 
proximity to the Ca2+ channels eliciting the Ca2+ rise (i.e. the IP3 or RyRs receptors in the 
ER/SR or different classes of channels on the plasma membrane such us voltage- and store-
operated channels) that is sufficient to stimulated the rapid accumulation of this cation. The 
idea of local Ca2+ microdomains between the mitochondria and the ER, was further 
demonstrated by Hajnoczky et al., and Rizzuto et al., by fast single-cell imaging of [Ca2+]mit 
with targeted Ca2+-sensitive GFPs (pericams and cameleons), which showed that [Ca2+]mit 
increases originate from a discrete number of ER-sites and then rapidly diffuse through the 
mitochondrial network. 
On the other hand, Ca2+ is extruded from the mitochondria by either a Na+/Ca2+ exchanger 
(mNCX) and a H+/Ca2+ exchanger (mHCX) expressed mainly in excitable and non-excitable 
tissue, respectively. 
The existence of a sophisticated machinery for Ca2+ handling supported the general 
consensus that mitochondria could actively and rapidly change their [Ca2+] and participate in 
cellular homeostasis (Patron et al., 2013). 
Mitochondrial Ca2+ Uniporter Complex: molecular identity and regulation 
 
Through the years, there has been a broad consensus that the key molecule that allow 
mitochondria to rapid accumulate a large amount of Ca2+ across the ion-impermeable inner 
channel is the electrophoretic pathway called MCU (Mitochondrial Calcium Uniporter). 
Before the recent discovery in 2011, several candidates have been proposed but all these 
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studies have been ineffective or identified putative channels that still wait experimental 
confirmations. In 2007, Graier’s group proposed that the isoforms 2 and 3 of the uncoupling 
protein UCP might be essential components of the uniporter machinery, but these data were 
not confirmed by other groups. Another research was performed by Clapham and coworkers 
who proposed Letm1 (leucine zipper EF-hand-containing transmembrane protein 1) as a 
H+/Ca2+ antiport. This result is until known a matter of debate because in contrast with 
previous results identifying this protein as a K+/H+ exchanger and in contrast with the 
established properties of Na+/Ca2+ (NCX) and H+/Ca2+ (HCX) antiporters. Letm1 appeared to 
be sensitive to the MCU inhibitor ruthenium red (RuR) and the best characterized antiporter 
inhibitor CGP37157 and not reduces Ca2+ accumulation. 
The best strategy for the identification of the molecular identity of MCU took advantage of a 
genome-wide approach. In 2008, Mootha and co-workers reported a mitochondrial 
“genoteque” called MitoCarta. It was obtained by performing mass spectrometry analyses, 
on both highly purified and crude mitochondrial preparations, from 14 different mouse 
tissues, in order to discover genuine mitochondrial proteins, further validated by GFP tagging 
(Pagliarini et al., 2008). By considering only those proteins localized in the IMM, expressed in 
the majority of mammalian tissues and with homologues in vertebrates and kinetoplastids 
(but not in yeast), they identified a protein named “Mitochondrial Calcium Uptake 1” 
(MICU1). MICU1 is a 54kDa protein possesses one transmembrane domain and two 
canonical EF-hands, essential for Ca2+-sensing. However, the presence of only one putative 
transmembrane domain made it unlike that it can function as a Ca2+ channel. MICU1 was 
thus recognized as a modulator of the Mitochondrial Calcium Uniporter (MCU) (Perocchi et 
al., 2010).  
The MitoCarta database and the discovery of MICU1 were the base for the subsequently 
discover of MCU. Our group screened in silico the MitoCarta database with the following 
parameters: i) ubiquitous expression in mammalian tissue, ii) minimal sequence 
requirements for channels (i.e. the existence of two or more transmembrane domains 
(TMDs), iii) absence in S.cerevisia, iv) presence in those organism in which mitochondrial Ca2+ 
transport with the properties of MCU was reported. Eventually, our and Mootha’s labs 
identified a protein, encoded by the CCDC109A gene, which satisfies all the requirements of 
the bona fide Mitochondrial Calcium Uniporter (Baughman et al., 2011; De Stefani et al., 
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2011). It was demonstrated that MCU localized to the inner mitochondrial membrane and its 
overexpression in Hela cells strongly increases the [Ca2+]mit while its down regulation 
drastically reduces it without affecting classical mitochondrial properties (i.e. organelle 
shape, ER-mitochondria contact sites, ATP synthesis, O2 consumption and ∆Ψ). De Stefani et 
al. demonstrated that MCU is necessary and sufficient to mediate mitochondrial Ca2+ uptake. 
Indeed, purified MCU formed a RuR-sensitive channel in planar lipid bilayers.  
Mitochondrial Potassium Channels 
 
The strict control of inner mitochondrial membrane permeability is vital for efficient ATP 
synthesis. Conversely, increased mitochondrial membrane permeability due to activation of 
mitochondrial megachannels is a hallmark of cell death (Szewczyk A. et al., 2009). Within this 
context, potassium transport via ion channels seems to be an important mechanism to 
control the integrity of inner mitochondrial membrane. In this way potassium channels have 
been proposed to play a central role in triggering cardio- and neuro- protection (Szewczyk A. 
and Marban, 1999; O’Rourke, 2004). The electrogenic transport of potassium ions into the 
mitochondrial matrix is strictly ion channel dependent and, accordingly, it looks like to 
plasma membrane ion channel activity. The basic biophysical properties of mitochondrial 
inner membrane potassium channels including ATP-regulated potassium (mitoKATP) channels 
(Inoue I. et al., 1991), large-conductance Ca2+ activated potassium (mitoBKCa) channels 
(Siemen D. et al., 1999), voltage-dependent potassium (mitoKv 1.3) channels (Szabo I. et al., 
2005) and twin-pore TASK-3 potassium channels (Rusznàk Z. et al., 2008) have been found to 
be similar to some potassium channels present in the plasma membrane of various cell 
types. Potassium channels in the inner mitochondrial membrane must be regulated in subtle 
ways to avoid collapse of the membrane potential (Szewczyk A. et al., 2009). 
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Fig.1. Overview of all electrophysiological activities in the IMM. 
The Mitochondrial Potassium Cycle 
 
Mitochondria are complex organelles. As reported in the general framework, they are 
composed by two different membranes, the outer mitochondrial membrane (OMM) and the 
inner mitochondrial membrane (IMM). The inner membrane contains the essential 
components of the electron transport proteins that transform the energy of substrate 
oxidation into an electrogenic proton efflux. The chemiosmotic theory, postulated by Peter 
Mitchell, is the basis for understanding the mitochondrial potassium cycle.  
K+ is the major monovalent cation in the cytoplasm (~150mM) and is consequently an 
important ion mediating changes in mitochondria volume when the K+ conductance of the 
inner membrane is altered. The high negative electrical membrane potential, generating by 
protons ejection trough the electron transport system, drives an electrophoretic K+ influx. 
Mitochondrial ATP-sensitive K+ channels (called mitoKATP) also allow the diffusion of K
+ inside 
the mitochondrial matrix. Net uptake of K+ salts is accompanied by osmotically obligated 
water, permeating through mitochondrial aquaporins, resulting in matrix swelling. Excess 
matrix K+ is then exported by the electroneutral K+/H+ antiporter, which uses the energy 
stored in the proton gradient to export K+ from the matrix (Fig.2). 
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Fig.2. The mitochondrial potassium cycle. 
 
The mitochondrial potassium cycle could be mimic in respiring mitochondria by the 
simultaneous use of two substances: ionophore valinomycin, which allows the rapid 
electrophoretic uptake of K+, causes massive mitochondrial matrix swelling, but the addition 
of nigericin, which promotes the electroneutral exchange of H+ and K+,  is able to prevent 
swelling but causes permeant depolarization and “uncoupling” (i.e. electron transport 
through components of the respiratory chain is not anymore coupled to ATP production). In 
intact mitochondria, energy dissipation is limited by the fact that channels and 
electrophoretic uptake pathways are strictly regulated. The so-called K+ cycle thus can 
potentially modulate the tightness of coupling between respiration and ATP synthesis, 
thereby maintaining a balance between energy supply and demand in the cell and 
controlling the magnitude of the Δ and ΔpH. 
From the literature, it is reported that potassium transport plays three distinct roles in 
mitochondria: i) volume homeostasis in order to prevent excess matrix swelling, that is 
essential for maintaining the structural integrity of the organelle. This function is mediated 
by the K+/H+ antiporter and was first proposed by Peter Mitchell; ii) volume homeostasis in 
order to prevent excess matrix contraction, function that maintains an expanded matrix 
when K+ influx diffuses inside the organelle. Maintaining matrix volume under these 
conditions is important because matrix contraction inhibits electron transport and also 
perturbates the structure-function of the intermembrane space (IMS). This volume 
regulation is mediated by the mitochondrial ATP sensitive K+ channels (mitoKATP); iii) cell 
signaling functions to protect the cell from ischemia-reperfusion injury. This function 
depends on the ability of mitoKATP opening to trigger increased mitochondrial production of 
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reactive oxygen species (ROS). The increased ROS levels activate a variety of kinases involved 
in the signaling pathways of cardioprotection. 
The mitochondrial ATP sensitive potassium channels 
 
The mitochondrial KATP channels (mitoKATP), namely its very existence, its composition, 
properties, regulation, functions and physiological and medical relevance, constitute the 
most controversial topic in the field of mitochondria channels. MitoKATP channel was initially 
described in liver mitochondria (Inoue I. et al., 1991). Later, it was also identified in heart, 
brain, kidney, skeletal muscle, human T lymphocytes and amoeba mitochondria. In 1980 and 
in 1988, two different laboratories tried to reconstitute a specific K+ uniporter, and this was 
reported by Mironova et al. and Diwan et al. They identified channel activity corresponding 
to an inner membrane protein of 53-57kDa but they weren’t able to obtain the exactly 
amino acid sequence. The channel was K+-selective but its regulation was not characterized. 
Only in 1991, Inoue and co-workers provided unequivocal evidence for the existence of K+ 
uniporters in the inner mitochondrial membrane by patch-clamping fused giant mitoplasts 
from rat liver mitochondria. They found the K+ uniport was inhibited by ATP and glyburide, 
and named these mitochondrial ATP-sensitive K+ channels (mitoKATP). Their work was 
followed by the purification and reconstitution of mitoKATP channels by Garlid’s group, an 
experimental setup that allowed detailed studies of the regulatory properties of this 
channel. Garlid’s group observed that mitoKATP exhibits many properties similar to those of 
the plasma membrane KATP channel.  
The plasma membrane KATP channel (pmKATP) act as an important sensor of the cellular 
metabolic/energetic state, closing when energy (ATP) is abundant, and opening when the 
cell is “starved”. pmKATP were first identified as 80pS channels by Noma in 1983 by 
experiments of patch clamping in cardiac myocytes (A. Noma., 1983), subsequently they 
have been found in many other cell types. For example, in pancreatic ß-cells pmKATP 
channels regulate glucose-stimulated insulin secretion and are the targets for sulfonylureas 
used to treat type 2 diabetes (F.M Ashcroft et al., 1999); in vascular smooth muscle they 
regulate vascular tone and in skeletal muscle, pmKATP may be active in fatigue (N.W.Davis et 
al., 1991). In cardiac muscle, they were originally thought to be involved in ischemic 
preconditioning and ischemic protection (G.J.Grover et al., 1989). From molecular point of 
18 
 
view, KATP channels are heterooligomers composed by a tetramer of ~40kDa Kir potassium 
channel-forming monomers associated with four regulatory sulfonylurea receptor 
(SUR)~160kDa subunits in an octameric complex. “Kir” stands for “K+-selective inward 
rectifier” and the name “inward rectification” is due to voltage-dependent block by 
cytoplasmic Mg2+ or polyamines. ATP-sensitive channels are formed by the members of the 
Kir6 group, which comprises Kir6.1 and Kir6.2. These “core” channels have an inhibitory ATP 
binding site, which can be modulates by phospholipids. Sulfonylurea receptors (SURs) are 
members of the family of ATP binding cassette (ABC) transporters. ABC transporters have 
been classified into seven subfamilies. The ones involved in the formation of KATP channels 
belong to the ABCC/MRP subfamily, which includes also, e.g., the cystic fibrosis 
transmembrane conductance regulator (CFTR). In this case, SUR do not act as “pumps”, and 
their function seems to be essentially that of regulating KATP channel activity. Each SUR 
monomer has three transmembrane domains (TMD0-2) and two cytoplasmic nucleotide 
binding folds (NBFs), each composed of a Walker A and B domain separated by a linker 
region- that come together to generate two interacting site that can bind MgATP/MgADP. 
Involvement of these sites promotes activity of the channel and induces the state of closure. 
Mutating the lysine in Walker A or the aspartate in Walker B in either of the NBDs of SUR 
causes loss of MgADP activation of the channel (Nichols C.G. et al., 1996). The major SUR 
forms are SUR1 with high affinity for sulfonylurea, SUR2A (cardiac) and SUR2B (smooth 
muscle) with lower affinity for sulfonylurea. These are the proteins generally considered to 
partner with Kir6.x in the formation of pmKATP channels. For both Kir6.x and SURs, the 
expression of one or the other form is organ-and cell-type specific and different forms of 
heterocomplexes may coexist in the same cell (Fig.3). 
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Fig.3. Tissue-dependent molecular composition of plasmamembrane KATP channels. 
The molecular composition of mammalian mitoKATP channel is a debated matter. A large 
consensus supports the idea that mitoKATP appears to be qualitatively similar to the pmKATP 
channel counterpart. The first important evidence about the molecular structure was with 
Garlid’s group that partially purified a mitochondrial fraction with mitoKATP channel activity 
(inhibited by ATP and activated by diazoxide) that contains, among several other proteins, 55 
and 63kDa components. They proposed that the 63kDa protein in the fraction is the 
sulfonylurea binding subunit (mitoSUR) and the 55kDa is the pore forming unit of the 
channel (mitoKir). However, the identity of these protein remain elusive and until know is 
not clear who are the proteins that composed the molecular structure of mitoKATP channel.  
An important role has been assigned to mitoKATP, especially in the heart, in protection from 
I/R injury, preconditioning and post conditioning. The process of ischemic preconditioning 
(IPC) was first described by Murry and coworkers in 1986 (Murry et al., 1986). IPC refers to a 
phenomenon in which brief episodes of hypoxia provide protection against a subsequent 
more prolonged period of ischemia (Murry et al., 1986; Kloner et al., 1998; Cohen et al., 
2000). This protection includes a reduction in both infarct size and the incidence of cardiac 
arrhythmias. The belief that a mitoKATP acts as crucial element has probably influenced their 
tracing and the interpretation of some of the observations. Diazoxide, considered as a 
specific mitoKATP opener, was reported to protect mitochondrial functionality during 
ischemia. Garlid’s group also showed that ATP-sensitive K+ flux in mitochondria could be 
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inhibited by 5-HD, a know inhibitor of pmKATP. In figure 4 is reported a table about the 
modulators of pmKATP and mitoKATP channel. 
 
Fig.4. Modulators of KATP channels and their selectivity toward mitochondrial and surface channels. 
It is unclear how the opening of a K+ channel in the mitochondria would lead to 
cardioprotection. However, three hypotheses have emerged to explain the link between 
mitoKATP channel opening and cardioprotection: (1) a decrease in the mitochondrial Ca
2+ 
uptake, (2) swelling of the mitochondrial matrix and changes in ATP synthesis, and (3) 
changes in the levels of reactive oxygen species (ROS). Regarding the first hypothesis, 
diazoxide has been shown to reduce the mitochondrial Ca2+ uptake, and the effect can be 
reversed by 5-HD (Holmuhamedov et al., 1999). This change in mitochondrial Ca2+ uptake is 
thought to be mediated by a partial depolarization of ∆Ψ in response to mitoKATP opening. 
Murata et al., 2011 showed that opening of mitoKATP induces a reduction of Ca
2+ 
accumulation in the mitochondria during simulated ischemia reperfusion. Regarding the 
second hypothesis, it has been known for some time that the opening of mitoKATP causes 
mitochondrial matrix swelling, and that this in turn activates the respiratory chain providing 
more ATP to support the recovering myocardium (Halestrap, 1989; Grover and Garlid, 2000; 
O’Rourke, 2000). Garlid’s group proposed that matrix swelling may lead to a more optimal 
contact between membrane proteins on the inner and outer membranes of the 
mitochondria, which may induce to an increase in ADP transport and ATP synthesis. About 
the third hypothesis, the ROS generated during the preconditioning period is thought to be 
protective (Vanden Hoek et al., 1989; Pain et al., 2000; Forbes et al., 2001). However, the 
ROS that is produced during reperfusion causes cell death (Ozcan et al., 2002). It is thought 
that the opening of mitoKATP results in an increase in the protective ROS produced during 
21 
 
preconditioning phase and a decrease in the levels of ROS- generated during reperfusion 
phase (O’Rourke., 2004). In summary, the exact physiological role of mitoKATP and the 
mechanism of its involvement in cardioprotection will be proven only following its definitive 
molecular identification. 
Calcium-dependent potassium channels 
 
Two types of calcium-activated potassium channels have been described in various cell 
types: mitoBKCa (Big conductance potassium channel) and mitoIKCa (Intermediate 
conductance channel). Planar lipid bilayer experiments and direct patch clamping of 
mitoplasts of mammalian cells show that mitoBKCa channel has a conductance of 100-300ps 
(Skalska J. et al., 2008). The channel has been identified in glioma cell line as well as in 
ventricular cells, rat skeletal muscle and brain (Skalska et al., 2009). Evidence for its presence 
in mitochondria has also been provided by Western blot, electron microscopy and 
immunofluorescence microscopy. The channel is activated by micromolar concentrations of 
calcium and by the drugs 12,14-dichlorodehydroabietic acid (diCl-DHAA), NS1619 and 
NS11021, CGS7181, and CGS7184. It is blocked by specific inhibitors such as charybdotoxin, 
iberiotoxin and paxilline (Heinen et al., 2007). Concerning the molecular nature of mitoBKCa, 
it seems quite similar with that of the pmBKCa. MitoBKCa has been proposed to be activated 
under pathophysiological conditions that increase mitochondrial Ca2+ uptake, thus 
preventing excessive mitochondrial Ca2+ accumulation (by partially depolarizing the IMM, 
the driving force for calcium influx is reduced) and may also play a physiological role to fine-
tune mitochondrial volume and/or Ca2+ accumulation under condition of, e.g. increased 
cardiac workload. Opening of mitoBKCa, similarly to mitoKATP, has been reported to protect 
against damage to the heart and other organs caused by ischemia and reperfusion. The 
protective effect of BKCa openers has been attributed to increased matrix K
+ uptake and 
volume, improved respiratory control, inhibition of mitochondrial Ca2+ overload and 
prevention of permeability transition pore (PTP) opening (Cheng Y. et al 2008). Opening of 
BKCa in isolated brain mitochondria was shown to inhibit ROS production by respiratory chain 
complex I and was hypothesized to be beneficial for neuronal survival. 
MitoIKCa has been recently observed by patch clamping mitoplasts isolated from human 
colon carcinoma cells (De Marchi U. et al., 2009) but it is reported in other cell types such as 
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in Hela of human cervix adenocarcinoma origin and in mouse embryonic fibroblasts (Sassi N. 
et al., 2010). The channel is selectively inhibited by clotrimazole and TRAM-34. The 
biophysical and pharmacological properties of the mitoIKCa and of the pmIKCa channels of the 
same cells are indistinguishable, and the molecular weights of the IKs in the two membranes 
are the same (Sassi N. et al., 2010). MitoIKCa may have a protective role similar to that 
proposed for mitoBKCa and mitoKATP channels; however, its physiological role has not been 
studied in detail so far. 
Mitochondrial Kv1.3 potassium channel 
 
Kv1.3 is a highly selective channel expressed in the plasma membrane of various cells. It 
plays a crucial role in the regulation of proliferation in lymphocytes (Cahalan M.D., Chandy 
K.G., 2009) as well in other cell types. Its presence in the mitochondria (mitoKv1.3) has been 
reported in T lymphocytes, macrophages, hippocampal neurons and presynaptic neurons, 
using patch clamp and/or immunochemistry. The molecular identification of the 
mitochondrial channel was obtained thanks to specific inhibitors margatoxin, and ShK and to 
a genetic model consisting in Kv1.3 KO CTLL-2 and CTLL-2 stably expressing Kv1.3 (Szabo I., et 
al 2005). Interestingly, the channel described in the mitochondria of hippocampal neurons 
by patch clamp displayed a different conductance with respect to the one found in 
lymphocytes, but both channels were sensitive to margatoxin. While pmKv1.3 activation is 
associated with cell proliferation (Cahalan M.D., Chandy K.G., 2009), its mitochondrial 
counterpart has been found to play a role in cell death. Concerning the mechanism, 
mitoKv1.3 was identified as a novel target of the pro-apoptotic Bcl-2 family protein, Bax and 
a physical interaction between the two proteins was shown to occur, but only in apoptotic 
cells. Recombinant Bax inhibited Kv1.3 channel activity with an efficiency similar to that 
observed to for the specific toxin inhibitors margatoxin or Shk. Incubating Kv1.3 positive 
isolated mitochondria with Bax or nanomolar concentrations of margatoxin or Shk -triggered 
apoptotic events, whereas mitoKv1.3 deficient mitochondria were resistant. The results 
indicated that during apoptosis, inhibition of IMM-located mitoKv1.3 by Bax leads to 
hyperpolarization, which results in the reduction of respiratory chain components and in 
enhanced production of ROS (Szabo I. et al., 2005). ROS is emerging as a key player in 
promoting cytochrome c release from mitochondria (Kaul S. et al., 2005). ROS are indeed 
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able to oxidase thiol groups and thus activate the PTP whose opening leads to depolarization 
and has been correlated to cytochrome c release. All these events, know to take place at 
mitochondria in various apoptotic models, were dependent on the presence of mitoKv1.3 
and did not occur in mitochondria of Kv1.3- deficient CTLL-2/pJK cells. Whether mitoKv1.3 is 
the only channel of the Shaker voltage-gated potassium channel family located in 
mitochondria and whether its presence is obligatorily linked to its presence in the plasma 
membrane are still under investigation. 
Two-pore potassium channel TASK-3  
 
Recently TASK-3 (Twink-related acid-sensitive K+ channel-3;KCNK9), a two-pore potassium 
channel know to reside in the plasma membrane, was identified in mitochondria of 
melanoma and keratinocyte cells by immunochemical and molecular biology methods 
(Rusznak Z. et al., 20008). In the pm, TASK-3 has a role in apoptosis and tumorigenesis (Patel 
A.J., Lazdunski et al., 2004). An investigation of the functional properties of the IMM TASK-3 
channel by electrophysiology and/ or spectroscopic methods remains to be performed. 
Notably, a TASK-3 knock down melanoma cell line displays compromised mitochondrial 
function, suggesting that TASK-3 channels are functionally present in the mitochondria of 
the melanoma cells, and their function is essential for the survival of these cells (Kosztka L. et 
al., 2011). 
Inward Rectifying Potassium Channel of the outer mitochondrial membrane 
 
Although the outer membrane of mitochondria is widely accepted to be freely permeable to 
small ions due to the presence of the voltage-dependent anion channel, VDAC, a recent 
paper describes the discovery of an inwardly rectifying voltage-dependent potassium 
selective ion channel (Kir) in this membrane by patch clamp experiments (Fieni F. et al., 
2010). The channel was regulated by osmolarity and cAMP and was found to be blocked by 
cesium. However, inhibition by other classical potassium channel inhibitors, TEA+ and 4-
amino-pyridine, was not achieved. The molecular nature of this channel as well as its single 
channel conductance remain to be clarified. Furthermore, further studies will need to 
exclude that this activity is related to a cationic subconductance state of VDAC or is the 
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result of a contamination by ER via the so-called mitochondria-associated endoplasmatic 
reticulum membranes (MAMs) (Hayashi T. et al., 2009). 
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AIM 
 
In 2011, the long searched mitochondrial calcium uniporter (MCU) was finally identified. 
MCU is a 40kDa protein with two transmembrane domains and is sufficient to reconstitute 
Ruthenium Red-sensitive Ca2+-selective channel activity in vitro. The availability of this 
molecular information opened the molecular era of mitochondrial Ca2+ signaling (De Stefani 
et al., 2011). When I started my PhD project, the original goal was to identify novel MCU 
interactors. Indeed, an in silico analysis revealed a strong potential candidate, namely coil-
coiled domain 51 (CCDC51). Similarly to MCU, CCDC51 is a widely expressed gene, conserved 
among vertebrates and encoding for a protein with two transmembrane domains. However, 
the structure and function of CCDC51 were never investigated before. We thus started to 
study this protein in order to test whether it could modulate mitochondrial Ca2+ 
accumulation. Although its overexpression causes profound changes in organelle Ca2+ 
homeostasis, we soon realized that CCDC51 was not a direct regulator of the MCU complex. 
Nonetheless, the effect triggered by CCDC51 overexpression was so fascinating that we 
decided to fully dissect its function. In particular, we reasoned that the effects triggered by 
CCDC51 overexpression could be explained through an increase of cation permeability of the 
inner mitochondrial membrane. We wondered whether CCDC51 could be act as an ion 
channel per se. We here identify a mitochondria localized protein complex that mediates 
ATP-sensitive potassium currents, the so-called mitoKATP. Similarly to its plasma membrane 
counterpart, the mitoKATP is formed by a pore-forming subunit, named mitoK (previously 
known as CCDC51), and an ATP-sensitive subunit, named mitoSUR (previously known as 
ABCB8). The new goal of my research is to elucidate the precise molecular composition, as 
well as the physiological role of the mitoKATP in vitro.  
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RESULTS 
1. In silico analysis 
The Mitochondrial Calcium Uniporter (MCU) is the Ca2+ channel of the inner mitochondrial 
membrane required for rapid Ca2+ accumulation inside organelle matrix. I started this project 
with the original goal to identify new MCU modulators by performing an in silico screening of 
putative MCU interactors. We thus performed a bioinformatics analysis looking for all the 
proteins fulfilling the following criteria: 
 Mitochondrial localization 
 With no homologues in Saccharomyces cerevisiae 
 With at least one transmembrane domain 
 Possessing at least one coiled-coil domain, structural motifs that proteins use to 
interact with other proteins or to form oligomers. 
 
We obtained a list of 10 proteins that includes Ccdc90a, Ccdc90b, Chchd1, Chchd2, Chchd3, 
Chchd4, Chchd7, Ccdc58, Ccdc44 and Ccdc51. Most of these proteins are already 
characterized in the literature, but one of them, encoded by the CCDC51 gene (NCBI gene ID 
79714), is completely uncharacterized. The gene that codifies CCDC51 is located on the short 
arm of chromosome 3 in humans, while in mice is on chromosome 9. Functional predictions 
based on primary amino acidic sequence show the presence of two transmembrane domains 
(Fig.1A). 
 
Fig.1A. CCDC51 includes two transmembrane domain. Schematic representation of the predicted 
domains in the CCDC51 protein. 
 
CCDC51 is a protein of unknown functions, since there are no papers in the literature 
investigating its physiopathological role. We thus started looking to its function by testing 
CCDC51 as a putative regulator of the mitochondrial Ca2+ channel MCU. 
27 
 
2. Real-time PCR analysis 
We performed real-time PCR analysis of mouse tissue (mRNA extraction and real-time PCR 
was performed as described in the Methods section). Tissue expression profiling showed 
ubiquitous presence in all investigated tissue (Fig.2A), suggesting that CCDC51 could play a 
widespread housekeeping role in all cells, similarly to MCU. 
 
Fig.2A. CCDC51 is ubiquitously expressed in mouse tissues. Real-time PCR analysis of mouse tissues. 
mRNA extraction and real-time PCR was performed as described in the Methods section. Expression 
levels are normalized to PolR2f. 
 
CCDC51 expression levels correlate with those of MCU, except for skeletal muscle, lungs and 
brain (Fig.2B): this data can in principle support the hypothesis of CCDC51 as a regulator of 
the Mitochondrial Calcium Uniporter. 
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Fig.2B. CCDC51 is ubiquitously expressed in mouse tissues, similarly to MCU. Real-time PCR analysis 
of mouse tissue. mRNA extraction and real-time PCR was performed as described in the Methods 
section. Expression levels are normalized to PolR2f.  
3. Biochemical characterization  
 3.1 Localization and topology 
First, we looked to the localization of the endogenous protein by fixing Hela cells and 
marking them with primary antibody capable of recognizing and displaying CCDC51 protein  
 
 
Fig.3.1A. Endogenous CCDC51 localize to mitochondria. Hela cells were fixed and 
immunocytochemistry was performed with α-CCDC51 and α-HSP60 antibodies followed by incubation 
with Alexa488, Alexa555 conjugated secondary antibodies as described in the Methods. 
Representative confocal images are shown. 
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with fluorescent secondary antibody conjugated with AlexaFluor488. Immunofluorescence 
staining showed full co-localization with mitochondria marker HSP60 conjugated to 
AlexaFluor555 (Fig.3.1A). 
Then, in order to better study the functional role of CCDC51, we cloned and expressed the 
protein in Hela cells. We analyzed the localization of the overexpressed protein compared 
the subcellular distribution of endogenous CCDC51, by co-expressing tagged version of 
CCDC51 (CCDC51-GFP and CCDC51-Flag) and proteins that are able to localize at the level of 
mitochondria (i.e. mtRFP or HSP60) and carrying out immunofluorescence. Hela cells were 
transiently co-transfected with mtRFP, in order to mark mitochondria, and CCDC51 
conjugated to GFP tag. After 36 hours of expression, by laser scanning confocal microscopy 
(LSCM) mitochondria have been identified mtRFP by exciting at wavelength of 543nm, while 
the CCDC51-GFP protein was excited at 488nm. Confocal images showed a complete overlap 
of the two emitted fluorescence, supporting the mitochondrial distribution of CCDC51 
(Fig.3.1B). 
 
Fig.3.1B. CCDC51-GFP localizes to mitochondria. Hela cells were transfected with CCDC51-GFP and 
mtRFP. After 36 hours the cells were fixed and representative confocal images are shown. 
 
This result was also confirmed by immunofluorescence staining of transfected Hela cells with 
CCDC51-Flag and mitochondrial marker HSP60 (Fig.3.1C). 
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Fig.3.1C. CCDC51-Flag localizes to mitochondria. Hela cells were transfected with CCDC51-Flag. After 
36 hours the cells were fixed and immunocytochemistry was performed with α-Flag and α-HSP60 
antibodies followed by incubation with AlexaFluor488, AlexaFluor555 conjugated secondary 
antibodies as described in Methods. Representative confocal images are shown. 
 
The membrane localization of CCDC51 was further evaluated in deeper detail by sub-cellular 
fractionation followed by mitochondrial sub-fractionation. Mouse liver tissue was 
homogenized with a Dounce homogenizer and centrifuged at 1000g (2300rpm) in order to 
separate entire cells and nuclei. The supernatant was then centrifuged at 7000g (9000rpm) 
to pellet the crude mitochondrial fraction. Mitoplasts, mitochondria lacking the outer 
mitochondria membrane, were obtained by osmotic swelling by incubating the 
mitochondrial fraction in 20mM HEPES for 20 min. Mitochondria and mitoplast fractions 
were then subjected to carbonate extraction. Na2CO3 is a salt that, following 
ultracentrifugation, allows to separate membrane protein from soluble ones. Western blot 
allowed us to identify the correct localization of CCDC51 at the level of mitochondria.  
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Fig.3.1 D-E. CCDC51 localizes at the inner mitochondrial membrane. (D) Immunoblot analysis of 
CCDC51 in the indicated fractions obtained from mouse liver, using antibodies against MCU (inner 
mitochondrial membrane) and CCDC51. (E) Membranes (i.e. pellet) were extracted from isolated 
mitochondria and probed with the indicated antibodies. 
Western blot analysis showed that CCDC51 is enriched in mitochondria compared to the 
total homogenate, confirming immunofluorescence data that show CCDC51 is a 
mitochondrial protein. It is also further enriched in mitoplasts indicating that CCDC51 can be 
located either in the inner mitochondrial membrane or into the matrix (Fig.3.1D). In 
addition, Western blot analysis of carbonate extraction showed that CCDC51 is present 
exclusively in the pellet fraction (Fig. 3.1E), thus indicating that is an integral membrane 
protein. Taken together, these data indicate that CCDC51 is a membrane protein of the inner 
mitochondrial membrane. 
In order to dissect the precise membrane topology, we took advantage of the availability of 
two different CCDC51 antibodies, one raised against the N-terminal, and the other covering 
the C-terminal, as indicated in figure 3.1G. We then performed a protease protection assay 
in isolated mitoplasts. In this method, proteinase K can access all proteins exposed outside 
the inner mitochondrial membrane. Conversely, all proteins residing inside the organelle are 
protected from enzymatic digestion. Proteinase K is used at the concentration of 100µg/ml 
and it is allowed to act at first for 10 min, then for 30 min. Enzymatic digestion is finally 
blocked with PMSF (phenylmethanesulfonyfluoride), a general inhibitor of serine proteases. 
In order to check the correct proteolytic activity of the protein, 1% Triton X100 is added to 
mitochondrial treated with proteinase K. Proteins are then loaded on SDS-PAGE and 
analyzed through Western blot.  
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As demonstrated by figure 3.1F, the antibody against CCDC51N-terminal revealed the 
appearance of a 25kDa band after treatment with Proteinase K for 10 and 30 minutes, while 
the 45kDa band (corresponding to the full length CCDC51 protein) is progressively reduced in 
intensity. This pattern indicates that Proteinase K has partially digested the protein, but a 
portion of CCDC51 remains protected (i.e. the band at approximately 25kDa). This indicate 
that region recognized by CCDC51N-terminal antibody is protected from proteinase K 
treatment, and thus resides inside organelle matrix. Conversely, the C-terminal region of the 
protein completely disappears after protein digestion, thus revealing its localization outside 
the organelle. As expected, in this experimental settings HSP60, a protein located inside 
mitochondrial matrix, is fully protected from Proteinase K digestion (Fig.3.1F-G). 
 
Fig.3.1F-G. Membrane topology of CCDC51. (F) Immunoblot analysis of mitoplasts from Hela cells 
and treated with proteinase K for the indicated time. These samples were probed using antibodies 
against CCDC51N-term, CCDC51C-term and HSP60. (G) Schematic representation of CCDC51 organization 
and domains recognized by antibodies.  
 
 3.2 FRET analysis 
In order to better understand the structure of the protein, we used a FRET-based assay to 
assess in situ protein-protein interactions.  
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For this purpose, a CCDC51-GFP (donor) and a CCDC51-mCherry (acceptor) chimera were 
generated and compared with two non-interacting fluorophores (GFP and mCherry). We 
confirmed the occurrence of FRET by monitoring fluorescence acceptor photobleaching. 
mCherry was bleached in a defined region with a 592nm high power laser and changes in 
CCDC51-GFP (excitation at 488nm) and CCDC51-mCherry (excitation at 543nm) fluorescence 
were measured. When FRET occurs, acceptor photobleaching leads to the de-quencing and 
consequent increase in donor fluorescence. Thus, FRET was calculated as the normalized 
increase in donor fluorescence after acceptor bleaching. Figure 3.2A shows a representative 
experiment. When CCDC51-GFP and CCDC51-mCherry were co-expressed, significant FRET 
could be detected (15,47% ± 6,2), whereas minimal FRET was detected when GFP and 
mCherry were not fused to CCDC51 (0%) (Fig.3.2B). The calculated efficiency is in line with 
other reports using the same FRET pair (Goh et al., 2011; van der Krogt et al., 2008) and does 
not correlate with the expression level of the fluorescent proteins. 
 
Fig.3.2A-B. CCDC51 forms oligomers in vivo. (A) Hela cells were transfected with GFP and mCherry or 
CCDC51-GFP and CCDC51-mCherry and analyzed after 24h. Images of donor and acceptor were taken 
before and after photobleaching of the indicated region (white box). FRET was calculated as detailed 
in the experimental procedures. (B) Histogram bar diagram shows FRET efficiency of the indicated 
donor and acceptor pairs. 
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We used the MCU-GFP/MCU-mCherry pair as positive control, since they already known to 
interact and form oligomers. (Raffaello A., et al. 2013). 
 
 
 
4. Effects of CCDC51 overexpression on mitochondrial functions 
 4.1 CCDC51 overexpression induces a drastic decrease of mitochondrial calcium 
uptake 
In order to test the hypothesis that CCDC51 could be a possible modulator of MCU, we 
verified the role of CCDC51 in mitochondrial Ca2+ handling. Ca2+ measurements were then 
carried out with aequorin-based-mitochondrial and cytosolic Ca2+ probes (mtAEQ and 
cytAEQ).  
CCDC51 overexpressing (CCDC51-V5 and CCDC51-GFP) and control Hela cells were perfused 
with modified Krebs-Ringer buffer supplemented with 1mM CaCl2 (KRB) and were 
challenged, where indicated, with 100µM histamine, an inositol 1,4,5-trisphosphate-
generating agonist causing Ca2+ release from endoplasmic reticulum.  
In control cells, the [Ca2+]cyt rise evoked by histamine stimulation was ± 3,1µM. We can 
observe no differences in cytosolic calcium accumulation in CCDC51 overexpressing cells (± 
3µM after 36h of transfection) (Fig. 4.1A-B). 
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Fig.4.1A-B. CCDC51 overexpression does not change [Ca2+]cyt in Hela cells. Cells were transfected 
with pcDNA3.1 and CCDC51-V5 or CCDC51-GFP. After 36h, [Ca2+]cyt uptake upon histamine 
stimulation was measured (n=6). 
These data indicate that the overexpression of CCDC51 in Hela cells does not affect the 
cytosolic calcium accumulation. 
We then measured mitochondrial Ca2+ levels in these same experimental groups in order to 
evaluate if the protein CCDC51 has an effect in the regulation of mitochondrial calcium 
accumulation. 
 
 
Fig.4.1C-D. CCDC51 overexpression critically reduces [Ca2+]mt in Hela cells. Cells were transfected 
with pcDNA3.1 and CCDC51-V5 or CCDC51-GFP. After 36h, [Ca2+]mt uptake upon histamine 
stimulation was measured (n=6, ***p<0.001) 
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Histamine stimulation shows that the overexpression of CCDC51 causes a drastic reduction 
in agonist- induced [Ca2+]mt peak compared to control cells, supporting the notion that only 
mitochondria are affected (Fig.4.1C-D). 
In order to selectively investigate the contribution of mitochondria Ca2+ machinery, we also 
measured mitochondrial calcium uptake in digitonin permeabilized cells. This experiment 
allows evaluating the properties of the mitochondrial Ca2+ uptake machinery independently 
of the ER Ca2+ release and the formation of microdomains of high [Ca2+] in close proximity  to 
mitochondrial calcium channel. Measurements in digitonin-permeabilizied cells are 
performed initially by perfusing cells with Intracellular Buffer (IB) for 60s. Cells are then 
perfused with the same buffer with 50µM digitonin for 60second, in order to permeabilized 
the plasmatic membrane, and washed with IB/EGTA buffer for other 60second. The 
mitochondrial [Ca2+] rise is then triggered by perfusing digitonin-permeabilized cells with a 
solution containing 2 µM.  Also in this experiment, overexpression of CCDC51 decreases the 
uptake rate (Fig.4.1E-F). Thus indicating that CCDC51 selectively impairs mitochondrial 
calcium accumulation. 
 
 
 
Fig.4.1E-F. CCDC51 overexpression critically reduces [Ca2+]mt in Hela permeabilized cells. Cells were 
transfected with pcDNA3.1 and CCDC51-V5. Experiment for valuate mitochondrial Ca2+ uptake in 
permeabilized cells were performed as described in Material and Method section. 
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 4.2 The overexpression of CCDC51 decreases mitochondrial calcium uptake 
irrespective of MCU levels 
In order to further test if CCDC51 could exert a role in the regulation of mitochondrial 
calcium accumulation by MCU, we overexpressed both proteins on Hela cells and we tested 
the mitochondria calcium accumulation with aequorin-based mitochondrial Ca2+ probes 
(mtAEQ). 
 
 
 
 
Fig.4.2A-B. CCDC51 overexpression critically reduces [Ca2+]mt in the overexpression of MCU. Hela 
cells were transfected with pcDNA3.1, MCU and CCDC51. After 36h, [Ca2+]mt uptake upon histamine 
stimulation was measured (n=6,** p<0.05, ***p<0.001). 
MCU overexpression per se caused an increase in the [Ca2+]mt rise (De Stefani et al., 2011), 
CCDC51 overexpression not only decreased the [Ca2+]mt rise evoked by 100µM histamine, 
but markedly reduced it even when MCU is overexpressed together (Fig.4.2A-B). This 
suggests that the effect of CCDC51 is independent of the amount of the MCU in the cells, 
thus suggesting that CCDC51 is not a modulator of the uniporter. 
 4.3 CCDC51 is not an MCU interactor 
We looked for biochemical confirmation of the previous result by using the FRET technique 
in living cells. We generated and imaged different combinations of GFP- and mCherry- 
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tagged MCU and CCDC51 proteins respectively. FRET was evaluated by acceptor 
photobleaching, as described above. Representative fluorescence images of the MCU-GFP 
(donor) and CCDC51-mCherry (acceptor) pair are shown in figure 4.3A. No significant FRET 
was observed (2,4% ± 1,6) compared to positive control (MCU-GFP and MCU-mCherry) 
(Fig.4.3B), thus indicating the absence of direct interaction between MCU and CCDC51. 
 
 
 
Fig.4.3A-B. CCDC51 and MCU do not interact in vivo. Hela cells were transfected with MCU-GFP and 
CCDC51-mCherry and analyzed after 36h. Images of donor and acceptor were taken before and after 
photobleaching of the indicate region (white box). FRET was calculated as detailed in the 
experimental procedures. Histogram bar diagram shows FRET efficiency of the indicate donor and 
acceptor pairs. 
 
This data supports the idea that CCDC51 is not a modulator of MCU. After ruling out the 
possibility of a direct effect of CCDC51 on organelle Ca2+ uptake machinery, we started 
investigating other mitochondrial parameters that may justify the large decrease in 
mitochondrial calcium accumulation caused by CCDC51 overexpression. 
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 4.4 CCDC51 overexpression induces a drastic decrease of mitochondrial membrane 
potential 
First, we tested the hypothesis that suppression of mitochondrial Ca2+ transients could be 
secondary to a decrease of mitochondrial membrane potential. It is indeed well known that 
the electrochemical potential (∆Ψ) is formed in energized mitochondria and it is composed 
by an electrical component (∆µ) and a proton concentration gradient (∆pH). The 
mitochondrion-selective tetramethylrhodamine methyl-ester (TMRM) dye was used to 
measure the mitochondrial membrane potential. This compound is membrane-permeant 
cation, that easily distributes into various compartments according to their electrochemical 
gradient. The accumulation of TMRM in mitochondria is driven by their membrane potential 
(-150/-180mV). In order to avoid the self-quenching of the probe, cells are loaded with a low 
TMRM concentration (20nM). Changes in mitochondria membrane potential will result in 
differences in absolute fluorescence intensity. The specificity of the signal is verified by 
collapsing the ∆Ψ through the treatment with the protonophore FCCP (10µM). 
Hela cells were transfected with p-EGFP, as control, or CCDC51-GFP. 36 hours after 
transfection, cells were loaded with TMRM and left for 30 minutes at 37°C. Then, we 
acquired two images, one to discriminate transfected and untransfected, the other to 
measure the mitochondrial membrane potential. After the acquisition of a stable baseline, 
we added FCCP that induces the collapse of mitochondrial membrane potential and allowed 
us to calculate the residual fluorescence in the absence of potential.  
 
As shown in figure 4.4, the overexpression of CCDC51-GFP protein caused a drastic decrease 
of mitochondria membrane potential compared to control cells, a result that can fully 
explain the reduction in mitochondria calcium accumulation.  
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Fig.4.4. CCDC51 overexpression decreases mitochondrial membrane potential. Hela cells were 
transfected with pEGFP or CCDC51-GFP. 36h after transfection, cells were loaded with 
tetramethylrhodamine (TMRM) and fluorescence was measured as described in Material and 
Methods section (n=6). Representative traces of one control and one CCDC51 overexpressing cells are 
shown. 
 4.5 CCDC51 overexpression induces a disarrangement of cristae structure 
In order to further investigate the consequences of CCDC51 overexpression on 
mitochondrial structure and function, we analyzed mitochondrial ultrastructure through 
electron microscopy.  
The mitochondrion is structurally defined by its two membranes: a limiting outer membrane 
that enwraps the energy-trasducing inner membrane, which in turn encloses a dense, 
protein-rich matrix. The outer membrane is topologically simple, varying in shape depending 
on whether the mitochondrion is in a cell (usually tubular when attached to the 
cytoskeleton, sometimes reticulated) or isolated in suspension (ellipsoidal or spherical). The 
inner membrae, which has a much large surface area than the outer membrane, contains 
features referred to as cristae, which have long been represented as simple infoldings of this 
membrane (Carmen A. Manella., 2006). 
Hela cells were transfected with p-EGFP (as control) and CCDC51-GFP, and 36 hours after 
transfection cells were fixed and imaged through Transmission Electron Microscopy (TEM). 
Mitochondria usually form elongated structures in control cells. In CCDC51-GFP expressing 
cells, mitochondria became dot-like structures (Fig.4.5A). 
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Fig.4.5A. CCDC51 overexpression leads to organelle fragmentation and swelling. Representative 
trasmission electron microscopy images of mitochondria in control and CCDC51 overexpressing Hela 
cells. 
TEM images showed that the overexpression of CCDC51-GFP protein induces a total collapse 
of cristae and mitochondria appears to be empty compared to control cells. 
The experiments performed so far show that the overexpression of CCDC51 induces a 
decrease in mitochondrial calcium accumulation that is secondary to a substantial decrease 
of mitochondrial membrane potential. One potential explanation is that CCDC51 could be a 
component of the Permeability Transition Pore (PTP). 
Indeed, opening of PTP pore increases ion permeability of the inner mitochondrial 
membrane, thus leading to organelle depolarization. PTP opening can be inhibited by 
cyclosporine A, which binds cyclophilin D, a peptidyl-prolyl cis-trans isomerase located in the 
mitochondrial matrix.  In order to analize a possibile correlation between the PTP and 
CCDC51, Hela cells that overexpress CCDC51 protein were grown in the presence of 
cyclosporine (50µM) and the mitochondrial calcium uptake was measured with aequorin-
based mitochondrial Ca2+ probes (mtAEQ). 
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Fig.4.5B-C. CCDC51 is not a CsA-sensitive PTP component. Hela cells were transfected with pcDNA3.1 
and CCDC51 in the presence of cyclosporine A. After 36h, [Ca2+]mit uptake upon histamine stimulation 
was measured (n=4,** p<0.05, ***p<0.001) 
As shown in figure 4.5B-C, CsA induces an increase of mitochondrial calcium uptake in 
control cells. This effect is in line with an increase of mitochondrial membrane potential 
caused by the inhibition of the transient opening on PTP. However, it is not the case for Hela 
cells that overexpressed CCDC51, where even in the presence of CsA we can observe a 
decrease of mitochondria calcium uptake. This result suggests that CCDC51 is not a 
component or a modulator of the PTP. 
 4.6 CCDC51 overexpression induces mitochondrial fragmentation 
Mitochondria are dynamic organelles that fuse and divide to form constantly changing 
tubular networks in all eukaryotic cells. Furthermore, regulation of mitochondrial dynamics 
is crucial for the health of the cells, because it is essential for cellular development and 
homeostasis, as well as apoptosis. The cytoplasmic dynamin-related GTPase DRP1 plays a 
key role in mitochondrial fission, while Mfn1, Mfn2 and Opa1 mediate organelle fusion. 
In order to test if CCDC51 could be involved in mitochondria dynamics we analyzed 
mitochondrial morphology when the protein is overexpressed. Hela cells were transiently 
co-transfected with mtRFP and CCDC51. Confocal images clearly showed that the 
overexpression of CCDC51 induces mitochondrial fragmentation (Fig.4.6A). 
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Fig.4.6A. CCDC51 overexpression leads mitochondrial fragmentation. Hela cells were transfected 
with CCDC51 and mtRFP. 36 hours after transfection cells were fixed and representative confocal 
images are shown. 
CCDC51 overexpressing mitochondria appear as punctuate structures, suggesting either 
excessive mitochondrial fission or decreased organelle fusion. In order to further investigate 
a possible role of CCDC51 protein in this process, we analyzed mitochondria morphology 
after the overexpression of DRP1 (Dynamin-related protein 1) or its dominant negative form 
DRP1K38A, that inhibts the normal function of DRP1 thus leading to hyperfused 
mitochondria. 
Hela cells were transiently co-transfected with mtRFP and CCDC51, together with DRP1 or 
DRP1K38A. 
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Fig.4.6B. CCDC51 is not involved in mitochondrial  dynamics. Hela cells were transiently transfected 
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with CCDC51, DRP1, DRP1-K38A and mtRFP. After 36 hours the cells were fixed and representative 
confocal images are shown. 
Confocal images showed that the overexpression of DRP1 and CCDC51 alone caused 
mitochondrial fragmentation. On the contrary, the overexpression of DRP1-K38A alone 
induced mitochondrial elongation. When CCDC51 is overexpressed together with DRP1 
mitochondria were still obviously fragmented, with no major differences compared to cells 
overexpressing CCDC51 alone. Most importantly, mitochondria overexpressing both CCDC51 
and DRP1-K38A appeared fragmented (Fig.6B). This result underlines how the inhibition of 
mitochondrial fission was not sufficient to restore the phenotype that induce the 
overexpression of CCDC51 alone, thus suggesting that CCDC51 and DRP1 act on different 
cellular processes. 
Thus, these results suggest that CCDC51 is not directly implicated in mitochondrial fusion 
and fission dynamics.  
5. CCDC51 is a potassium channel 
CCDC51 overexpression leads to a major dysregulation of multiple mitochondrial 
parameters, including organelle fragmentation and swelling, loss of membrane potential and 
decrease of mitochondrial Ca2+ accomulation. All these effects can in principle be explained 
by an increase of cation permeability of the inner mitochondrial membrane. Indeed, similar 
effect can be mimicked by treatment with mitochondrial uncouplers, including valinomycin, 
a potassium ionophore (data not shown). 
We thus wondered whether CCDC51 could act as an ion channel. We analyzed channel 
activity of the purified protein reconstituted in a planar lipid bilayer. For this purpose, a His-
tagged CCDC51 construct was generated and expressed in a wheat-germ cell-free 
transcription/translation, where membrane contaminants are absent. The purified protein 
was inserted into lipid bilayers and its electrophysiological activity was assed in a medium 
containing 150mM KCl on both sides. In this experimental setup we observed a clear channel 
activity characterized by a conductance of 75pS. In addition, currents could be fully inhibited 
by tetraethylammonium (TEA) chloride, a general inhibitor of potassium channels (Fig.5A-B). 
these results indicate that CCDC51 is a potassium-permeant channel. 
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Fig.5A-B. Purified CCDC51 shows channel activity in lipid bilayers and it is inhibited by 
tetraethylammonium (TEA) chloride. (A) Electrophysiological recordings of purified CCDC51 in vitro 
and reconstituted in a planar lipid bilayers. (B) CCDC51 traces after addition of tetraethylammonium 
(TEA) chloride. 
We next wondered whether CCDC51 could be a part of the mitoKATP, given that all the other 
mitochondrial K+ channels (mitoBKCa, two-pore doomain TASK-3 and mitoKv1.3) were already 
identified.  
ATP-sensitive potassium-selective channels (KATP) mainly exist on the plasma membrane of 
excitable cells (pmKATP), but they are reported to be present also in some intracellular 
organelles. The mitochondrial ATP-sensitive potassium channels (mitoKATP) is one of the 
most controversial topics in the field of mitochondrial research, since even its very existence 
is a matter of debate. MitoKATP mediates the electrophoretic transport of potassium ions 
inside the organelle matrix, thanks to the large driving force represented by the 
mitochondrial membrane potential, and it is inhibited by normal physiological ATP 
concentrations.  Although CCDC51 per se  acts as ATP-insensitive (data not shown), we 
supposed that the ATP sensitivity could be conferred by a regulatory channel subunit, 
similary to what happens in pmKATP. Indeed, pmKATP channels are heterooligomers 
composed by a tetramer of Kir (K+-selective inward rectifier, i.e. the channel forming 
subunit) associated with four regulatory sulfonylurea receptor (SUR) subunits (belonging to 
the ABC superfamily), all arranged in an octomeric complex. 
We thus looked to ATP-binding proteins of the inner mitochondrial membrane and we found 
at least one good candidate. 
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 5.1 In silico analysis of ATP-binding proteins 
The ABC genes represent the largest family of transmembrane protein. Most of these 
proteins bind ATP and use the energy to drive the transport of various molecules across all 
cell membranes (Higgins 1992; Childs and Ling 1994; Dean and Allikmets 1995). Proteins are 
classified as ABC transporters based on the sequence and organization of their ATP-binding 
domains, also knows as nucleotide-binding fold (NBF). The NBFs contain characteristic 
motifs, Walker A and B, separated by <90-120 aminoacids, found in all ATP-binding proteins. 
The functional protein typically contains two NBFs and two transmembrane (TM) domains. 
The TM domains usually contain 6-11 membrane-spanning-helices. Four members of 
mitochondrial ABC system are already reported in literature. ABCB7, ABCB10 and ABCB8  are 
localized in the inner mitochondrial membrane, while ABCB6 is found in the outer 
mitochondrial membrane.  
However, we started from all ABC proteins located in mitochondria according to MitoCarta 
database. We thus obtained a list of 12 proteins that includes Abcb1a, Abcb1b, Abcb4, 
Abcb5, Abcb6, Abcb7, Abcb8, Abcb9, Abcb10, Abcb11, Tap1 and Tap2. Among them, we  first 
focused our attention to the mitochondrial protein ABCB8. It is a half-molecule ABC protein 
that localizes to the inner mitochondrial membrane (Ardehali H. et al., 2005), and apparently 
contains a single transmembrane and nucleotide binding domain (Hogue D.L. et al., 1999). 
ABCB8 has been shown to protect against oxidant induced cell death (Ardehali H. et al., 
2005), however its primary function is not known, although it was reported to be involved in 
mitochondrial iron transport (Yoshihiko Ichikawa et al., 2011). We prioritized this protein 
because it has the same tissue expression of CCDC51. In addition, mitochondria from ABCB8 
knock out mouse hearts show disruption of cristae and deformed morphology.  
 
 
ABCB8 +/+ ABCB8 ∆/∆ 
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Figure shows TEM images of hearts from Abcb8+/+ and Abcb8 ∆/∆ mice. Hearts from 
Abcb8+/+ mice show well aligned mitochondria with clearly distinguishable cristae. 
Mitochondria from Abcb8 ∆/∆ mouse hearts show disruption of cristae and deformed 
morphology. This phenotype resembles what we observed when CCDC51 is overexpressed in 
Hela cells.  We thus tested the physical and functional interactions between CCDC51 (called 
mitoK hereafter) and  ABCB8 (called mitoSUR hereafter). According to our hypothesis, the 
concomitant overexpression of mitoK and mitoSUR should restore the mitochondrial 
dysfunction caused by the overexpression of mitoK alone, since mitoSUR confers the correct 
gating and closes the mitoK channel in normal physiological conditions. 
6. Effects of mitoK and mitoSUR on mitochondrial functions 
 6.1 MitoK and mitoSUR physically interact  
In order to investigate if mitoK and mitoSUR interact each other, co-immunoprecipitation 
analysis was performed. Hela cells were co-transfected with mitoK-V5 and mitoSUR-Flag 
chimeras. 36 hours after transfection, the cells were lysed and immunoprecipitation was 
carried out using an α-Flag antibody as bait. When mitoK and mitoSUR were co-expressed, 
the α-Flag antibody immunoprecipitated mitoK, thus revealing the interaction (Fig.6.1). 
 
Fig.6.1. MitoK physically interacts with mitoSUR. Hela cells were transfected with the indicated 
constructs. Flag-tagged mitoSUR was immunoprecipitated from cells extract with a specific α-Flag 
antibody. The precipitated proteins were immunoblotted with α-Flag and α-mitoK antibodies. 
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 6.2 Effects of the co-expression of mitoK and mitoSUR on mitochondria calcium 
uptake 
In order to test if the physical interaction between mitoK and mitoSUR has a functional 
effect, we analyzed how the concomitant overexpression of the two proteins could affect 
mitochondrial Ca2+ responses. Ca2+ measurements were then carried out with aequorin-
based-mitochondrial Ca2+ probes (mtAEQ).  
As shown in figure 6.2A-B,overexpression of mitoK alone causes a significant decrease of 
mitochondrial calcium uptake after histamine stimulation. Conversely, the overexpression of 
the mitoSUR subunit alone does not affect organelle Ca2+ responses. Most importantly, the 
concomitant overexpression of the two subunits perfectly rescue mitochondrial Ca2+ 
dynamics, suggesting the restoration of mitochondrial membrane potential and 
consequently of the proper physiological channel activity.  
 
Fig.6.2A-B. MitoSUR inhibits mitoK channel activity. Hela cells were transfected with the indicated 
constructs together with mitochondrial-targeted aequorin probe and agonist induced peaks of matrix 
[Ca2+] was measured (n=6, ***p < 0.001) 
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 6.3 Effects of co-expression of mitoK and mitoSUR on mitochondria membrane 
potential 
To further support the previous finding, we measured the mitochondria membrane potential 
when mitoK and mitoSUR were concomitant co-expressed. The mitochondrion-selective 
tetramethylrhodamine dye (TMRM) was used to measure the mitochondrial membrane 
potential in Hela cells after the overexpression of mitoK and mitoSUR.  
As shown in figure 6.3, overexpression of mitoK alone causes a significant decrease in 
mitochondrial membrane potential. Conversely, the overexpression of mitoSUR subunit 
alone does not affect organelle functions. The concomitant overexpression of the two 
subunits rescue mitochondrial membrane potential, supporting what we observed with 
calcium experiments. 
 
 
 
Fig.6.3. MitoSUR inhibits mitoK channel activity. Hela cells were transfected with the indicated 
constructs. 36h after transfection, cells were loaded with tetramethylrhodamine methy (TMRM) ester 
and fluorescence was measured as described in Material and Methods section (n=6). 
 
 6.4 MitoSUR guarantees ATP inhibition  
As described above, mitoSUR belongs to the ABC superfamily. Mitochondrial ABC proteins 
bind to adenine nucleotides through theirnnucleotide-binding domains (NBDs). These 
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domains contain the conserved Waker A (G-X-X-G-X-G-K-S/T) and Walker B motifs ( ɸ-ɸ-ɸ-ɸ-
D, where ɸ represents a hydrophobic residue), which mediate ATP binding. 
In figure 6.4 we can observe the diagram of the structure of a representative ABC protein of 
the plasma membrane: the transmembrane domains form a pore throught the plasma 
membrane and associate with the nucleotide binding domains, which are found on the 
cytosolic face of the membrane. Stars indicate the ATP  binding sites. 
  
 
Fig. 6.4. Diagram of a typical ABC transporter protein. 
 
In order to confirm the specificity of the gating by intracellular nucleotides, we generated a 
mitoSUR mutant (mitoSURK513A) unable to bind ATP through site directed mutagenesis of the 
Walker motif, as shown in figure. 
 
 
We tested the mutant form of mitoSUR both in mitochondrial calcium and mitochondria 
membrane potential in the concomitant overexpression of mitoK.  
As shown in figure 6.4A-B, overexpression of mitoK alone causes a significant decrease of 
mitochondrial calcium uptake after histamine stimulation. Conversely, the overexpression of 
the mitoSURK513A subunit alone does not affect organelle functions, similarly to the 
overexpression of the wild type form of mitoSUR. Most importantly, the concomitant 
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overexpression of mitoK and mitoSURK513A subunit is not able to rescue the loss of 
mitochondrial calcium uptake caused by mitoK overexpression, thus enforcing the notion 
that ATP acts as channel inhibitor.  
 
 
 
Fig.6.4.A-B. MitoSUR guarantees ATP inhibition. (A-B) Hela cells were transfected with the indicated 
constructs together with mitochondrial-targeted aequorin probe and agonist induced peaks of matrix 
[Ca2+] was measured (n=6, ***p < 0.001). 
 
Similar results have been obtained for the measurement of the mitochondrial membrane 
potential. As shown in figure 6.4C, mitoSURK513A is not able to rescue the loss of 
mitochondrial membrane potential caused by mitoK overexpression. 
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 Fig. 6.4C. MitoSUR guarantees ATP inhibition. Hela cells were transfected with the indicated 
constructs. 36h after transfection, cells were loaded with tetramethylrhodamine (TMRM) methyl ester 
and fluorescence was measured as described in Material and Methods section (n=6). 
 
 6.5 Effects of co-expression of mitoK and mitoSUR in a planar lipid bilayer 
The data presented so far strongly support the notion that mitoK and mitoSUR form the 
long-sought mitoKATP. However, the unambiguous demonstration of their genuine channel 
activity and pharmacological profile necessarily relies on in vitro reconstitution approaches. 
We thus expressed both mitoK and mitoSUR in a cell-free transcription/translation system 
based on wheat germ lysate, where membrane contaminants are absent. We then purified 
the recombinant proteins and reconstituted them in  planar lipid bilayers. 
As shown in figure 6.5A-B, mitoK and mitoSUR together form a channel i) selective for 
monovalent cations, ii) sensitive to ATP, iii) activated by diazoxide, a well-known 
pharmacological activator of the mitoKATP. Overall, all these features recapitulate the 
fundamental traits of the mitoKATP. 
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Fig.6.5A-B. MitoK and mitoSUR form a functional mitoKATP  in vitro. Recombinant mitoK and 
mitoSUR were purified, reconstituted in a planar lipid bilayers and electrophysiological recordings 
were performed in 150mM KCl by adding the indicated compounds. 
 
7. Physiological role of the mitoKATP 
One of the key questions regarding the mitoKATP is how its activity impacts on organelle 
function. Although a number of hypothesis has been proposed and tested, significant 
discrepancies are present in the literature on the field. Most importantly, these 
experimental data rely uniquely on pharmacological approaches that lack selectivity. The 
discovery of the molecular identity of the mitoKATP finally allows testing its impact on 
mitochondrial functions by using genetic procedures.  
In order to investigate this aspect, we generate Hela cells knockout for mitoK by using the 
Crispr/Cas9 technology. Crispr (clustered regularly interspaced short palindromic repeats) 
are DNA loci containing short repetitions of base sequences. When paired with Cas9 
nuclease, Crispr can cleave genomic DNA in a site-specific manner, thus knocking out gene 
expression. Guide RNAs (gRNA) are designed to a specific genomic sequence thus directing 
Cas9 to knockout the gene. The gRNA is a short synthetic RNA composed of a “scaffold” 
sequence necessary for Cas-9 binding and a user-defined ~20 nucleotides “spacer” or 
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“targeting” sequence which defines the genomic target to be modified. In our case, two 
different guides targeting different gene regions are designed and together with Cas9 are 
cloned into lentiviral vectors, packaged into viral particles and transduced into target cells. 
The genomic target can be any ~20 nucleotide DNA sequence, provided it meets two 
conditions: i) the sequence is unique in the host genome, ii) the target is present 
immediately upstream of a Protospacer Adjacent Motif (PAM). The PAM sequence is 
absolutely necessary for target binding and the exact sequence is dependent upon the 
species of Cas9. In figure 7A, is reported the designed strategies for mitoK gene knockout.   
 
 
 
Fig.7A. Designed strategies for mitoK gene knockout. Overall organization of mitoK gene and insets 
containing the Crispr guide sequences (colored in red, PAM sequence is underlined); the genomic 
sequences of the resulting  Hela mitoK-KO clones are shown as chromatograms. 
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Several clones were grown and the efficient gene ablation was tested at protein level 
through Western blot. As shown in figure 7B, the resulting clones completely lack the mitoK 
protein. 
 
 
 
 
 
 
Fig.7B. Validation of mitoK-Knockout cells. Western blot of the selected clones probed with the 
indicated antibodies. 
 7.1 MitoK-KO cells show a peculiar ultrastructure 
In order to dissect the phenotype of Hela mitoKKO cells, we performed  transmission electron 
microscopy. Hela cells (as control), cells overexpressing mitoK and  mitoKKO cells  were plate 
in a 24 wells and  fixed for electron microscopy after 36 hours. 
 
 
Fig.7.1. MitoK-Knockout cells show a peculiare ultrastructure. Representative electron microscopy 
images of mitochondrial ultrasutructures in control,  overexpressed mitoK and mitoK-Knockout Hela 
cells. 
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As shown in figure7.1, mitochondria from control cells appeared as tubular structures with 
well-defined and tight cristae; mitochondria that overexpressed mitoK became dot-like 
structures and lost their tubular aspect (as reported in figure 7.1); most importantly, ablation 
of mitoK leads an impairment of mitochondrial ultrastructure with numerous abnormal and 
enlarged cristae. 
 
 7.2 MitoK-KO cells show flickering of mitochondrial membrane potential 
In order to further investigate if the particular structure of the cristae that characterized 
mitoK-KO cells could have an impact in other mitochondrial parameters, we measured the 
mitochondrial membrane potential with TMRM probe.  
In these cells, mitochondrial membrane potential is overall intact, but we noticed that Hela 
mitoK-KO cells undergo to asynchronous, rapid and transient depolarizations of single 
mitochondria, a phenomenon known as “flickering” or “flashes” of mitochondria membrane 
potential. Representative traces of this peculiar behavior can be found in fig. 7.2A, where the 
TMRM intensity of the highlighted individual organelles is tracked through time. We are also 
able to quantify the number of depolarization events every 5 minutes (Δm flickering) 
(Fig.7.2B), and demonstrated that the loss of mitoK leads to a drastic increase of Δm 
flickering frequency. 
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Fig.7.2A-B. Loss of mitoK triggers the flickering of mitochondrial membrane potential (∆Ψ). The 
indicated clones were loaded with TMRM and fluorescence was monitored for 5 minutes. (A) 
Representative traces show the normalized mean grey values of individual mitochondria trough time. 
(B) Representative TMRM images of one mitoKKO cell line at the indicated time points and quantitative 
analysis of flickering events. 
 
 7.3 MitoK-KO cells show an impairment of oxygen consumption rate (OCR) 
In order to further evaluate the role of mitoKATP in mitochondrial functions, we measured 
the oxygen consumption rate in control and mitoK-knockout Hela cells. This parameter was 
measured in intact cells by using of a Seahorse –XF Analyzer platform. Mitochondrial 
respiration was fist inhibited by addition of Oligomycyn (point A), then prompted by FCCP 
(point B) and finally dropped by Rotenone and Antymycin (point C and D).  
Oxygen consumption rate (OCR) is greatly impaired in Hela mitoK-KO cells when compared to 
their wild type counterparts, in both basal, leaky (i.e. olygomycin induced) and maximal (i.e. 
FCCP induced) respiration (Fig.7.3A). 
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Fig.7.3A. Loss of mitoK impairs mitochondrial respiration. Oxygen consumption rates of the 
indicated cell lines were measured through extracellular flux analyzer. 
 
In order to test if the impairment of mitochondrial respiration is due to a dysregulation of 
respiratory chain complexes, we analyzed the overall expression levels of ETC components 
through western blot analysis (Fig.7.3B). This revealed that the loss of mitoK causes no major 
defect in the expression levels of respiratory chain complexes compared to control Hela 
cells. 
 
Fig.7.3B. Loss of mitoK does not affect protein levels of ETC complexes. Proteins were extracted and 
blotted from the indicated cell lines and probed with the indicated antibody. 
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DISCUSSION AND CONCLUSION 
 
After decades of intense investigation, the molecular identity of the mitochondrial Ca2+ 
uniporter has been identified. This exciting result opened new developments in the 
clarification of the mechanisms of mitochondrial Ca2+ homeostasis, the regulation of cellular 
metabolism and cell survival. Of course, the discovery of MCU is only the beginning to 
understand the phenomenon of the accumulation of mitochondrial Ca2+. Indeed there are a 
lot of conditions that can change the dynamics of the [Ca2+]mt and consequently  several 
modulators of this channel must exist. At the beginning, the aim of my PhD research was to 
identify a protein that could play the role of MCU interactor. We started from the same 
approach that was used for the identification of the Mitochondrial Calcium Uniporter. We 
screened in silico the MitoCarta database, with the following parameters: i) ubiquitous 
expression in mammalian tissue, ii) presence in those organisms in which mitochondrial Ca2+ 
transport with the properties of MCU was reported, iii) presence of coil-coiled domains and 
iv) absence in S. cerevisiae. This analysis allowed us to identify an interesting candidate, the 
protein coiled-coil domain containing 51 (CCDC51). 
First, we confirmed the mRNA expression in multiple tissues through real-time PCR analysis, 
including, heart, kidney, liver, skeletal muscle and brain (Fig.2A). Overall, the expression 
profile was similar to that observed for the MCU in the same tissues (Fig.2B). This first data 
could therefore support our original hypothesis. Therefore, CCDC51 was cloned into plasmid 
vectors pcDNA3.1 with Flag, V5 or GFP tags in order to perform a detailed characterization of 
its biochemical features and functions. Immunofluorescence demonstrated the 
mitochondrial localization of the protein (Fig 3.1A-B-C). In order to understand the correct 
localization at sub-mitochondrial level, we have combined different biochemical techniques, 
including: isolation of mitochondria and mitoplasts (i.e. mitochondria lacking the outer 
mitochondrial membrane), extraction of soluble proteins with Na2CO3 and proteinase K 
protection assays. Western Blot analysis of these fractions showed that CCDC51 is a 
mitochondrial protein located either in the IMM or in the matrix, because its specific band is 
progressively enriched in the mitochondria and mitoplast fraction (and absent in the OMM 
or IMS) when compared with the total homogenate (Fig.3.1D). The assay with Na2CO3 allows 
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us to discriminate between soluble and membrane proteins. According to our data, CCDC51 
is a membrane protein, since it is present exclusively in the pellet fraction (Fig.3.1E). By 
combining these data, we concluded that CCDC51 is a protein of inner mitochondrial 
membrane. Finally, we performed a classical proteinase protection assay in order to 
understand the topology of the protein. Taking into account the presence of two predicted 
transmembrane domains, our data indicate that CCDC51 is located in the inner 
mitochondrial membrane with its NH2 terminal part and its COOH terminal parts exposed to 
the matrix (Fig.3.1F-G). 
These methods are able to characterize the protein from a structural point of view. 
However, our main aim is to understand the possible functions that the protein exerts at the 
level of mitochondria and its possible interaction with the MCU. First of all, to better 
understand the implication of CCDC51 in calcium homeostasis, we have studied the Ca2+ 
dynamics using aequorin-based probes in HeLa cells. We observed a strong decrease of 
agonists-induced mitochondrial Ca2+ transients (Fig.4.1C-D). This effect is not dependent on 
a deregulation of Ca2+ homeostasis in the other compartments. As an example, in the cytosol 
there are no differences between control and CCDC51-overexpressing cells (Fig.4.1A-B). 
Once identified the specific effect of CCDC51 at the level of mitochondria, we tested the 
hypothesis of a possible interaction with the uniporter. We studied the effects of a co-
expression of both proteins (MCU and CCDC51) on mitochondrial Ca2+ dynamics in Hela cells. 
In this experimental setup, CCDC51 can decrease mitochondrial Ca2+ accumulation even 
when MCU is overexpressed (Fig.4.2A-B). This indicates that the effect of CCDC51 is 
independent of the amount of the MCU in the cells, thus suggesting that CCDC51 may not be 
an MCU modulator. This information was further confirmed in the analysis of the interaction 
between MCU and CCDC51 through FRET analysis. The co-expression of both chimeras 
(MCU-GFP and CCDC51-mCherry) reveals no significant interaction between the two 
proteins (Fig.4.3A-B). Overall, we can exclude a direct effect of CCDC51 on the mitochondrial 
Ca2+ uptake machinery. 
We thus decided to investigate other mitochondrial parameters that may justify a reduction 
in Ca2+ accumulation. The impairment of mitochondrial Ca2+ uptake can be indeed secondary 
to changes in the driving force for Ca2+ accumulation (i.e. collapse of mitochondrial 
membrane potential, ∆Ψ), organelle shapes, ER-mitochondria contact sites. First of all, we 
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analyzed the effects of CCDC51 overexpression on mitochondrial morphology. The images 
acquired through laser scanning confocal microscopy show that the protein induces a clear 
mitochondrial fragmentation (Fig4.6A). We hypothesized that CCDC51 could be directly 
implicate in the mechanism of mitochondrial fission. Indeed, it is known that the proteins 
involved in this process produce mitochondrial fragmentation when overexpressed. To test 
this aspect, we analyzed confocal images of Hela cells that overexpressed CCDC51 in 
combination with DRP1 (Dynamin-related protein 1) -protein implicated in mitochondrial 
fission- and DRP1-K38A, the dominant negative form of DRP1 that prevents the formation of 
fragmented mitochondria. Confocal images suggest us to rule out a possible involvement of 
CCDC51 in the mecchanism of mitochondrial fission. Indeed, mitochondria that overxpress 
CCDC51 and DRP1-K38A are fragmentated, underline that the inihibition of fission (throught 
DRP1-K38A) is not sufficent to restore the phenotype that characterizes overexpression of 
CCDC51 (Fig.4.6B). Once excluded an implication in the regulation of mitochondrial 
morphology, we analyzed the effects of CCDC51 overexpression on cristae structure through 
electron microscopy and we observed that an overexpression of this protein induces a total 
collapse of cristae (Fig.4.5A). This aspect is in agreement with the secondary effects that we 
observed when CCDC51 is overexpressed in Hela cells. Indeed we measured the 
mitochondrial membrane potential using fluorescent indicator TMRM. The results have 
clearly shown that mitochondria that overexpressed CCDC51 are almost devoid of potential 
(Fig.4.4). Then, we hypothesized that this dysregulation could be due to a premature 
opening of the PTP. To test the possible involvement of the PTP has been used the most 
effective inhibitor, cyclosporine A (CsA). The experiment performed was to grow Hela cells in 
the presence of cyclosporine. The expected result is to appreciate a slight increase in [Ca2+] 
in control cells, and a decrease in [Ca2+] for cells that overexpressed CCDC51 like the same 
cells transfected with the protein but not treated with cyclosporine A (Fig.4.5B-C). However, 
our results didn’t validate our hypothesis. Even in the presence of cyclosporine, cells 
overexpressing CCDC51 showed the same decrease in mitochondrial calcium accumulation, 
indicating that the loss of mitochondrial membrane potential is not due to PTP opening. This 
data, together with the results on mitochondrial calcium accumulation and mitochondrial 
membrane potential, remarked that CCDC51 and MCU have an independent effect.  
63 
 
Overall, we demonstrated that CCDC51 overexpression leads to a major dysregulation of 
multiple mitochondrial parameters, including organelle fragmentation and swelling, loss of 
membrane potential and decrease of mitochondrial Ca2+ accomulation. All these effects are 
in line with an increase of cation permeability of the inner mitochondrial membrane and 
they are indeed mimicked by treatment with mitochondrial uncouplers, including 
valinomycin, a potassium ionophore. Taken together all these results, we thus hypotized 
that CCDC51 could be act as an ion channel. The only way to unambigously test this 
hypothesis is to investigate the function of the purified protein in an heterologous system. In 
order to get this fundamental piece of data, we first expressed the recombinant CCDC51 
protein in a wheat-germ cell-free transcription/translation system, and then inserted the 
purified protein into lipid bilayers. We then tested its electrophysiological activity in a 
medium containing 150mM KCl. We could demonstrated that CCDC51 is sufficient to form a 
functional channel. Importantly its activity was completely abolished by the addition of 
tetraethylammonium chloride, a general inhibitor of potassium channels. Thus CCDC51 
alone acts as potassium channel (Fig.5A-B). There are several potassium channel reported to 
be present at the level of the inner mitochondrial membrane (see Introduction). However, 
most of them (mitoBKCa, two-pore doomain TASK-3 and mitoKv1.3) already have a clear 
molecular composition, with the notable exception of the mitochondrial ATP-sensitive K+ 
chennel (mitoKATP). We thus wondered wether CCDC51 could be the mitoKATP. 
ATP-sensitive potassium channels (KATP) are K+-selective channels gated by intracellular 
nucleotides. They are primarily located at the plasma membrane (pmKATP), but several 
evidences indicate they are also present in intracellular membranes, in particular in the inner 
mitochondrial membrane (mitoKATP). The mitocondrial ATP-sensitive potassium channels is 
one of the most controversial topics in the field of mitochondrial reserch, since even its very 
existence is a matter of debate (Garlid KD, Halestrap AP., 2012). MitoKATP mediates the 
electrophoretic transport of potassium ions inside the organelle matrix, thanks to the large 
driving force represented by the mitochondrial membrane potential, and its inhibited by 
normal physiological ATP concentrations.  The main features of the mitoKATP were originally 
described 1991 through direct patch clamp of mitoplasts (Inoue I et al, 1991). Since then, the 
mitoKATP was well described from the pharmacological point of view and both channel 
openers (i.e diazoxide) and inhibitors (i.e sulphonylureas and 5-hydroxydecanote) have been 
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found (Szewczyk et al.,2002). Drugs targeting KATP channels are widely recogized to be useful 
in the treatment of several pathologies (Edwards G, Weston AH., 1993). Importantly, some 
of their therapeutic uses are due to the modulation of ATP-sensitive channels of the plasma 
membrane (pmKATP), but others largely depend on their effects on mitoKATP. Indeed, 
diazoxide efficiently protects the heart from ischemia reperfusion injury (Garlid K.D. et al., 
1997), even in the absence of cardiac pmKATP (Sato T. et al., 2000). However, despite the 
significant efforts that have been spent in this direction, the molecular identity of this 
channel remained elusive.  
Unfortunately, our data show that CCDC51 per se fails to show any ATP sensitivity. However, 
we reasoned that the ATP sensitivity could be conferred by a regulatory channel subunit, 
similary to what happens in pmKATP. Indeed, pmKATP channels are heterooligomers 
composed by a tetramer of Kir (K+-selective inward rectifier, i.e the channel forming subunit) 
associated with four regulatory sulfonylurea receptor (SUR) subunits (belonging to the ABC 
superfamily), all arranged in an octomeric complex. SURs do not act as “pumps”, and their 
function is essential to regulate KATP channels activity. Starting from this hypothesis, we 
looked to mitochondrial proteins of the ABC family. Among these, we found one particular 
promising candidate to act as putative SUR subunit. Indeed, the protein encoded by the 
ABCB8 gene share the same tissue expression of CCDC51. In addition, it has already been 
described to be involved in mitoKATP (Ardehali et al., 2005) and mitochondria derived from 
ABCB8-null mice display an overall ultrastructure resembling CCDC51-overespressing 
mitochondria. Our working hypothesis is that mitoKATP has the same overall molecular 
organization of KATP of plasma membrane: CCDC51 acts as K-permeant subunit (and will be 
thus named as mitoK hereafter), while ABCB8 acts as SUR subunits (and will be thus named 
as mitoSUR hereafter). According to this view, the concomitant overexpression of mitoK and 
mitoSUR should restore the mitochondrial dysfunction caused by the overexpression of 
mitoK alone, since the mitoSUR subunit confers the correct gating and closes the channel in 
normal physiological conditions. To confirm this hypothesis, we first check whether mitoK 
and mitoSUR interact each other. Co-immunoprecipitation experiment shown in figure 6.1 
demonstrate the physical interaction between these two proteins. Then, we measured both 
mitochondrial membrane potential and organelle calcium transients. As shown in figure 
6.2A-B and in figure 6.3, overexpression of mitoK alone causes a significant decrease of both 
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these parameters. Conversely, the overexpression of the mitoSUR subunit alone does not 
affect organelle functions. Most importantly, the concomitant overexpression of the two 
subunits perfectly rescue mitochondrial membrane potential and Ca2+ dynamics, suggesting 
the restoration of the proper physiological channel gating. Overall, the data presented so far 
strongly support the notion that mitoK and mitoSUR form the long-sought mitoKATP. 
However, the best way to demonstrate that mitoK and mitoSUR form a functional channel is 
in vitro reconstitution approach. We thus tested the co-expression of mitoK and mitoSUR in 
a cell-free transcriptional/translation system based on wheat germ lysate. We then purified 
the recombinant proteins and reconstituted them in planar lipid bilayers. Strikingly, mitoK 
and mitoSUR together form a channel i) selective for monovalent cations, ii) blocked by 
tetraethylammonium chloride (TEA), iii) sensitive to ATP (Fig.6.5A), iv) activated by diazoxide 
(Fig.6.5B). Overall, all these features recapitulate the fundamental profile of the mitoKATP.  
In order to confirm that ABCB8 is the mitoSUR subunit that can regulate the activity of mitoK 
through ATP binding, we generated a mitoSUR mutant (mitoSURK513A) unable to bind ATP 
through site direct mutagenesis of the Walker motif. This mutant is not able to rescue the 
loss of mitochondrial calcium accumulation and mitochondrial membrane potential caused 
by mitoK overexpression (Fig.6.4A-B-C), thus enforcing the notion that ATP act as channel 
inhibitor. 
Much of the debate on the mitoKATP is focused on its physiological role. According to the 
available literature, mitoKATP channels are believed to be protective in ischemia-reperfusion 
injury. However, the broad conservation profile among all vertebrates suggests that the 
mitoKATP should also have a primary housekeeping function. In order to analyze this aspect, 
we generated Hela cells knockout for mitoK by using the Crispr/Cas9 technology. Two 
different guides targeting different gene regions were designed (Fig.7A) and several Hela 
mitoK-KO clones were obtained (Fig.7B). Overall, ablation of mitoK leads to no gross defects in 
mitochondrial morphology, although an impairment of cristae structure become evident 
through electron microscopy (Fig.7.1). Mitochondrial membrane potential is overall intact, 
but we noticed that Hela mitoK-KO cells undergo to asynchronous, rapid and transient 
depolarizations of single mitochondria, a phenomenon known as “flickering” of 
mitochondrial membrane potential. Representative traces of this peculiar behavior can be 
found in figure 7.2A-B, where TMRM intensity of the highlighted individual organelles is 
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tracked through time. Although expression of respiratory chain complex is unaffected 
(Fig.7.3B), oxygen consumption rate (OCR) is greatly impaired in Hela mitoK-KO cells when 
compared to their wild type counterparts, in both basal and maximal (i.e FCCP induced) 
respiration (Fig.7.3A). As already reported, mitochondrial K+ homeostasis is fundamental to 
regulate mitochondrial matrix volume: while excessive accumulation leads to organelle 
swelling, a decrease in K+ uptake is predicted to cause matrix contraction (Garlid K.D., 
Paucek P., 2003), with obvious expected consequences on the performance of the oxidative 
phosphorylation.  
Overall, our data indicates that mitoKATP is a central regulator of mitochondrial function that 
modulates the efficiency of energy production according to the ATP availability through the 
regulation of matrix volume. Based on strong and robust preliminary data, we have now 
identified the key molecular components of the mitoKATP. This important discovery allows the 
investigation of the structure, the function and the pathophysiological role of the mitoKATP 
channels. This research proposal will revitalize a poorly explored topic in organelle biology 
and will provide novel molecular targets with potential high therapeutic impact. 
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MATERIAL AND METHODOS 
Bioinformatic screening 
 
The MitoCarta database was screened for ubiquitously expressed proteins and proteins 
containing one or more transmembrane domains predicted using the TMHMM algorithm 
and at least one predicted coiled-coil domain predicted using PCOILS. Sequences of these 
candidates were retrieved and aligned with the Saccharomyces cerevisiae proteome by a 
standard Gonnet matrix to exclude homologues. All alignments with a P-value <0.001 were 
excluded. Out of 1158 proteins present in MitoCarta, only 10 fulfilled these requirements.  
Cell culture, transfection and proteomic analysis 
 
All the experiments were performed in HeLa cells cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) (Lifetechnologies), supplemented with 10% Fetal bovine serum (FBS) 
(Lifetechnologies), containing penicillin (100 U/ml) and streptomycin (100µg/ml). For some 
experiments we used also Hek293A cultured in the same conditions of Hela cells.  
Cells were cultured in Galaxy-S incubator at 37°C and 5% CO2. 
Cells were transfected with a standard Ca2+-phosphate procedure. For Ca2+-phosphate 
transfection procedure the following stock solution need to be prepared and conserved at -
20°C until used: 
- CaCl2 2.5 M. 
- HEPES Buffered Solution 2X (HBS): 280 mM NaCl, 50 mM Hepes, 1.5 mM Na2HPO4, pH 7.12. 
All solutions were sterilized by filtration using 0.22 μm filters. Just before the transfection 
procedure, cells are washed with fresh medium. For one 13 mm coverslip, 5 μl of 2.5 M CaCl2 
were added to the DNA dissolved in 45 μl of H2O. Routinely, 4 μg of DNA were used to 
transfect 1 coverslip. The solution was then mixed under vortex with 50 μl of HBS and 
incubated for 20 to 30 minutes at room temperature. For one 24 mm coverslip the amount 
of solution and DNA were doubled while for 10cm dishes was used 50 μl of 2.5M CaCl2, 20μg 
of DNA in 450 μl of H2O and 500 μl of HBS. The transfection mix was then added directly to 
the cell monolayer. Sixteen hours after addition or the DNA, cells were washed with PBS 
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(two or three times until the excess precipitate is completely removed). Experiments were 
carried out 24-36 hours after transfection. 
 
Western blotting and Antibodies 
 
To monitor endogenous and overexpressed protein regulation, cells were lysate in RIPA-
buffer (150 mM NaCl, 50 mM Tris, 1 mM EGTA, 1% Triton X-100, 0.1% SDS) and after 30’ of 
incubation on ice, 40 μg of total proteins were loaded, according to BCA quantification. 
Proteins were separated by SDS-PAGE electrophoresis, in commercial 4-12% acrylamide gels 
(Life technologies) and transferred into nitrocellulose membranes (Life technologies) by wet 
electrophoretic transfer. Blots were blocked 1 hour at RT with 5% non-fat dry milk (BioRad) 
in TBS (0.5M Trizma –Sigma, 1.5M NaCl) solution (0.01% Tween) and incubated over night at 
4°C with primary antibodies. Secondary antibodies were incubated 1 hour at RT. Washes 
after antibody incubations were done on an orbital shaker, three times for 10’each, with 
TBS-0,01% tween.  
We used the following antibodies: anti-CCDC51c-term (1:10000, Sigma), anti-CCDC51N-
term(1:1000, Sigma) ,anti-GRP75 (1:1000, Santa Cruz), anti-HSP60 (1:5000, Santa Cruz), anti-β-
tubulin (1:7500, Santa Cruz), anti-Flag (1:1000, Cell Signaling).  
Secondary, HRP-conjugated antibodies (1:5000) were purchased from BioRad. 
Co-immunoprecipitation 
 
For the interaction between mitoSUR-Flag and mitoK, Hela cells were transfected with a 
calcium-phosphate procedure. After 48 hours of expression cells were lysate in an 
appropriate volume of lysis buffer (150mM NaCl, 1% Digitonin, 50mM Tris-HCl pH7.4, 1mM 
EGTA-Tris pH 7.4 and Complete EDTA-free protease inhibitor mixture (Roche Applied 
Science). Lysates were centrifuged at 13.000 r.p.m. for 10 min, and supernatant was 
transferred into new tubes. 1mg of proteins from the different conditions was incubated 
with Control Agarose Resina (Thermo) for 30 min at 4°C. This passage is called pre-clearing 
and reduce nonspecific binding of proteins to agarose beads. The precleared eluates were 
then centrifuged at 13.000r.p.m. for 10 min and the supernatant was incubated with 
monoclonal α-Flag-Agarose antibody (Sigma) for 3 hours at 4°C. When the lysate-beads 
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incubation time is over the tubes were centrifuged, the supernatants were removed from 
the beads and discard. The beads were washed with lysis buffer three times for 10 min in 
order to remove nonspecific binding. Then 50 µl of loading buffer 2X was added to the beads 
and the elution samples were boiled for 5 min at 95°C. The co-immunoprecipitation samples 
were analyzed by SDS-PAGE gel electrophoresis, transferred to Hybond-C Extra membrane 
(Amersham) and stained with Ponceau S solution. MitoSUR was visualized with polyclonal α-
Flag antibody (Cell Signaling) and mitoK with polyclonal α-CCDC51 antibody (Sigma). 
Aequorin as a Ca2+ indicator 
 
Aequorin is a 21 kDa photoprotein isolated from jellyfish Aequorea Victoria which emits blue 
light in the presence of Ca2+. The aequorin originally purified from the jellyfish is a mixture of 
different isoforms called “heterogeneous aequorin” (Shimomura, 1986). In its active form 
the photoprotein includes an apoprotein and a covalently bound prosthetic group, called 
coelenterazine. The apoprotein contains four helix-loop-helix “EF-hand” domains, three of 
which are Ca2+-binding sites. These domains confer to the protein a particular globular 
structure forming the hydrophobic core cavity that accommodates the ligand 
coelenterazine. When Ca2+ ions bind to the three high affinity EF-hand sites, coelenterazine 
is oxidized to coelenteramide, with a concomitant release of CO2 and emission of light (Head 
et al. 2000). Although this reaction is irreversible, an active aequorin can be obtained in vitro 
by incubating the apoprotein with coelenterazine in the presence of oxygen and 2-
mercaptoethanol. Reconstitution of an active aequorin (expressed recombinantly) can be 
obtained also in living cells by simple addition of coelenterazine into the medium. 
Coelenterazine is highly hydrophobic and has been shown to permeate cell membranes of 
various cell types. Different coelenterazine analogues have been synthetized and are now 
commercially available.  
The possibility of using aequorin as Ca2+ indicator is based on the existence of a well-
characterized relationship between the rate of photon emission and the free [Ca2+]. The first 
method used to correlate the amount of photons emitted to the free [Ca2+] was that 
described by Allen and Blinks (Blinks, 1978). In the following years, this system was improved 
to achieve a simple algorithm that converts luminescence into [Ca2+] values. Under 
physiological conditions of pH, temperature and ionic strength, this relationship is more than 
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quadratic in the range of [Ca2+] 10-5-10-7 M. The presence of 3 Ca2+ binding sites in aequorin 
is responsible for the steep relationship between photon emission rate and free [Ca2+]. The 
[Ca2+] can be calculated from the formula L/Lmax where L is the rate of photon emission at 
any instant during the experiment and Lmax is the maximal rate of photon emission at 
saturating [Ca2+]. The rate of aequorin luminescence is independent of [Ca2+] at very high 
(>10-4 M) and very low [Ca2+] (< 10-7 M). However, as described below in more details, it is 
possible to expand the range of [Ca2+] that can be monitored with aequorin.  
Although aequorin luminescence is not influenced either by K+ or Mg2+ (which are the most 
abundant cations in the intracellular environment and thus the most likely source of 
interference under physiological settings) both ions are competitive inhibitors of Ca2+ 
activated luminescence.  
pH was also shown to affect aequorin luminescence but at values below 7. Due to the 
characteristics described above, experiments with aequorin need to be done in well-
controlled conditions of pH and ionic concentrations, notably of Mg2+.  
Recombinant aequorins 
 
Aequorin began to be widely used when the cDNA encoding the photoprotein was cloned, 
thus avoiding the purification of the native polypeptide and its microinjection. Moreover, 
the cloning of aequorin gene opened the way to recombinant expression and thus has 
largely expanded the applications of this tool for investigating Ca2+ handling in living cells. In 
particular, recombinant aequorin can be expressed not only in the cytoplasm, but also in 
specific intracellular compartments by including specific targeting sequences in the 
engineered cDNAs (Hartl et al., 1989). Extensive manipulations of the N-terminal of aequorin 
have been shown not to alter the chemiluminescence properties of the photoprotein and its 
Ca2+ affinity. On the other hand, even marginal alterations of the C-terminal either abolish 
luminescence or drastically increase Ca2+ independent photon emission. For these reasons, 
all targeted aequorins synthesized in our laboratory include modifications of the 
photoprotein N-terminal. Three targeting strategies have been adopted:  
1. Inclusion of a minimal targeting signal sequence to the photoprotein cDNA. This strategy 
was initially used to design the mitochondrial aequorin and was followed also to synthesize 
an aequorin localized in the nucleus and in the lumen of the Golgi apparatus.  
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2. Fusion of the cDNA encoding aequorin to that of a resident protein of the compartments 
of interest. This approach has been used to engineer aequorins localized in the sarcoplasmic 
reticulum (SR), in the nucleoplasm and cytoplasm (shuttling between the two compartments 
depending on the concentration of steroid hormones), on the cytoplasmic surface of the 
endoplasmic reticulum (ER) and Golgi and in the subplasmalemma cytoplasmic rim.  
3. Addition to the aequorin cDNA of sequences that code for polypeptides that bind to 
endogenous proteins. This strategy was adopted to localize aequorin in the ER lumen.  
The construct used in our experiments is the mutated isoform of mitochondrial targeted 
aequorin (Brini M., 2008): mtAEQmut. It was generated to measure the [Ca2+] of the 
mitochondrial matrix of various cell types. This construct includes the targeting presequence 
of subunit VIII of human cytochrome c oxidase fused to the aequorin cDNA. To expand the 
range of Ca2+ sensitivity that can be monitored the photoprotein was also mutated 
(Asp119>Ala). This point mutation affects specifically the second EF hand motive of wild type 
aequorin. The affinity for Ca2+ of this mutated aequorin (mtAEQmut) is about 20 fold lower 
than that of the wild type. 
Luminescence detection 
 
The aequorin detection system is derived from that described by Cobbold and Lee (Cobbold 
and Bourne, 1984) and is based on the use of a low noise photomultiplier placed in close 
proximity (2-3 mm) with aequorin expressing cells. Cells are seeded on 13-mm coverslips and 
put into a perfusion chamber. The volume of the chamber is kept to a minimum (about 200 
μl). Cells are continuously perfused via peristaltic pump with KRB saline solution, 
thermostated via a water bath at 37°C.  
The photomultiplier (Hamamatsu H7301) is kept into a dark box. The output of the amplifier- 
discriminator is captured by C8855-01-photoncounting board in an IBM compatible 
microcomputer and stored for further analysis.  
Experimental procedures for Ca2+ measurements 
 
Cells were seeded onto 13 mm glass coverslips and allowed to grow to 50% confluence. The 
day before measuring, cells were transfected with mtAEQmut aequorin plasmid (as 
previously described) together with the indicated plasmid.  
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The following day, coverslips with cells were incubated with 5 μM coelenterazine for 2 hours 
in KRB saline supplemented with 1mM CaCl2, and then transferred to the perfusion 
chamber. All aequorin measurements were carried out in KRB saline solution. Agonists and 
other drugs were added to the same solution. The agonist stimuli used for maximal 
stimulation were: 100 μM histamine or 100 μM ATP, depending on the cell type.  
The experiments were terminated by lysing cells with 100 μM digitonin in a hypotonic Ca2+-
rich solution (10 mM CaCl2 in H2O), thus discharging the unbound aequorin pool. The light 
signal was collected and calibrated into free [Ca2+] values by an algorithm based on the Ca2+ 
response curve of aequorin at physiological conditions of pH, [Mg2+] and ionic strength, as 
previously described (Brini M., 2008). 
Measurement of Mitochondrial Membrane Potential 
 
The measurement of mitochondrial membrane potential is based on the distribution of the 
mitochondrion-selective lipofilic cation ”tetramethyl rhodamine methyl ester” dye (TMRM, 
Life Technologies). It is fluorescent and membrane permeable and its distribution into 
intracellular compartments is controlled by electrochemical gradients. Hence, at low 
concentrations, its accumulation into mitochondria is driven by mitochondrial membrane 
potential (almost -180mV). In order to promote the correct distribution of the probe, cells 
were loaded with the dye-solution at very low concentration (20nM). Changes in 
mitochondrial membrane potential cause a redistribution of the dye between mitochondria 
and cytoplasmic environment. Cells were loaded with TMRM stock solution (in KRB saline 
solution) for 20’ at 37°C. The probe was excited at 560 nm and the emission light was 
recorded in the 590-650 nm range.  
Images were taken every 10 s with a fixed 200 ms exposure time. FCCP (carbonyl cyanide p-
trifluoromethoxyphenylhydrazone, 10 μM), an uncoupler of oxidative phosphorylation, was 
added after 12 acquisitions to completely collapse the electrical gradient established by the 
respiratory chain (ΔΨ). Data are expressed as difference between the TMRM fluorescence 
before and after FCCP depolarization. Imaging was performed in a wide field epifluorescence 
microscope (Zeiss Axiovert 200), equipped with a PlanFluar 40X/1.3NA objective, high-speed 
monochromator (PTI) coupled to a 75 W xenon arc lamp and an EMCCD camera 
(Photometris Evolve 512 Delta). 
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Förster Resonance Energy Transfer (FRET) 
 
Hela cells were grown on 24 mm coverslips and transfected with the indicated combination 
of GFP, CCDC51-GFP, MCU-GFP, mCherry, CCDC51-mCherry or MCU-mCherry encoding 
plasmids when 50% confluent. GFP and mCherry were excited at 488 and 543 nm and their 
signals were collected in the 495-535 and 598-670 nm range respectively. A specific region of 
the specimen was bleached with a 1.5W 592 nm laser (4 passes at 30% power). Donor and 
acceptor were collected before and after bleaching and FRET efficiency was calculated from 
the background subtracted images with the formula:  
 FRET=  Donorpost - Donorpre  * 100                                                                                               
 
 Where Donorpre and Donorpost are the mean fluorescence intensities in the selected region 
before and after bleaching. As internal control, no significant FRET was observed outside the 
bleached region. No bleaching of the donor was observed with this experimental setting. 
Pinhole was set to 1 airy unit and pixel size was adjusted to 150nm. Representative images 
were generated using the AccPbFRET plugin (Roszik et al., 2008) for ImageJ. All images were 
taken on a LEICA TCS STED CW system equipped with a 100x/1.4 N.A. Plan Apochromat 
objective. 
Morphological analysis 
 
 Immunofluorescence 
 
HeLa cells were grown on 24 mm coverslips and transfected with CCDC51-Flag, CCDC51-GFP, 
and/or mtRFP encoding plasmid. After 24/36 hours, cells were washed with PBS, fixed in 4% 
formaldehyde for 10 minutes and quenched with 50 mM NH4Cl in PBS. Cells were 
permeabilized for 10 minutes with 0.1% Triton X-100 in PBS and blocked in PBS containing 
2% BSA for 1 hour. Cells were then incubated with primary antibodies (anti-Flag or anti-
CCDC51) for 3 hours at room temperature and washed 3 times with 0.1% Triton X-100 in 
PBS. The appropriate isotype matched AlexaFluor conjugated secondary antibodies 
Donorpost 
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(Lifetechnologies) were used and coverslips were mounted with ProLong Gold Antifade 
reagent (Lifetechnologies). Confocal images were acquired on a Leica SP5-TCS-II-RS. For all 
images, pinhole was set to 1 airy unit, pixel size was about 100 nm and a Z-stack was 
acquired for the whole depth of the cell by sampling at 130 nm in the Z plane. 488 nm Ar-
laser line was used to excite GFP and its signal collected in the 492-537 nm range, while RFP 
fluorescence was excited by the 543 nm HeNe laser and its emission was collected in the 
555-700 nm range. For each image, PMT gain was slightly adjusted in order to maximize 
signal and avoid saturation. Quantification of the number and the volume of the 
mitochondria were performed from ImageJ program. 
Oxygen Consumption Rate Experiments 
 
Mitochondrial respiration was followed in a kinetic mode by measuring the oxygen 
consumption rate (OCR) of cell monolayers with XFe Extracellular Flux Analyzer (Seahorse 
Bioscience) at 37°C. Baseline oxygen consumption rate (OCR) was measured followed by 
injections sequentially with oligomycin (2µM) to measure the ATP linked OCR, oxidative 
phosphorylation uncoupler FCCP (0.6µM) to determine maximal respiration, and rotenone 
(1µM) and antimicyn (1µM) to determine the non-mitochondrial respiration.  Every point in 
traces represents the average of 6 different wells.  
RNA extraction, reverse transcription, and quantitative realtime PCR 
 
For the expression analysis of CCDC51 in mouse tissue, adult male C57BL/6 mice (28-30g) 
were used. Skeletal muscle (tibialis anterior), heart, brain, spleen, lung, liver kidney and 
visceral fat were excised from three age-matched animals. Total RNA was purified using SV 
Total RNA Isolation kit (Promega) following manufacturer instructions. The RNA was 
quantified with an Eppendorf Bio photometer Plus. From 400 nmol of total RNA of each 
sample, complementary DNA was generated with a cDNA synthesis kit (SuperScript II, 
Invitrogen) and analyzed by real-time PCR using the SYBR green chemistry (Bio-Rad). The 
primers were designed and analyzed with Primer3 (Rozen and Skaletsky, 2000). Real-time 
PCR standard curves were constructed by using serial dilution of cDNAs of the analysed 
samples, using at least four dilution points and the efficiency of all primer sets was between 
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98 and 102%. The housekeeping genes Pol2Rf were used as an internal control for cDNA 
quantification and normalization of the amplified products. 
Constructs 
 
Mouse CCDC51 was amplified from mouse skeletal muscle cDNA library by PCR using the 
following primers.  
For cloning into pEGFP-N1: fw,5’-CTCGAGATGACAGGGTGCAGCCCCGT-3’; rv, 5’-
GGATCCCGACTGGTCTTGAACAGCATGT-3’. The PCR fragment was cloned into XhoI and 
BamHI sites in pEGFP-N1 (Clonotech).  
For the cloning of CCDC51-Flag into pcDNA3.1: fw, 5’- AAGCTTATGACAGGGTGCAGCCCCGT-
3’; rv, 5’-CTCGAGTTACTTATCGTCGTCATCCTTGTAATCACTGGTCTTGAACAGCATGT-3’. The PCR 
fragment was cloned into HindIII and XhoI in pcDNA3.1 (Invitrogen).  
For the cloning of CCDC51-V5 into pcDNA3.1: fw, 5’- AAGCTTATGACAGGGTGCAGCCCCGT-3’; 
rv,5’CTCGAGTTACGTAGAATCGAGGAGACCGAGAGGGTTAGGGATAGGCTTACCACTGGTCTTGAA
CAGCATGT-3’. The PCR fragment was cloned into HindIII and XhoI in pcDNA3.1 (Invitrogen). 
For the cloning of CCDC51 in pIVEX 1.3 WG: fw, 5’- CCATGGCAACAGGGTGCAGCCCCGTGTT-
3’; rv, 5’- CTCGAGACTGGTCTTGAACAGCATGT-3’. The PCR fragment was cloned into NcoI and 
XhoI in pIVEX1.3 WG (Roche). 
For ABCB8 construct we used the commercial one from Origene pmCV6-ABCB8 (RC224948). 
For the cloning of ABCB8 in pIVEX 1.3 WG: fw, 5’-GCGATCGCCCATATGCTGGTGCATTTA-3’; rv, 
5’- CTACCGAGTACTTTAAACCTTATC-3’. The PCR fragment was cloned into NheI anD BamHI in 
pIVEX1.3 WG (Roche). 
The generation of the pmCV6-ABCB8K513A  mutant was performed by mutagenesis PCR using 
the wild type pmCV6-ABCB8 vector as template and the mutagenesis primer: 5’-
GGCCAGTCTGGCGGAGGAGCGACCACCGTGGCTTCCCTG-3’. 
All constructs were verified by Sanger sequencing. 
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Protein expression and purification 
 
In vitro: mitoK and mitoSUR were cloned into pIVEX1.3 WG, as described above. In vitro 
expression was performed by using a RT100 Wheat Germ CECF Kit (Roche). After expression, 
the reaction mix was solubilized with 2% Triton X-100 for 90min at 30°C under shaking. 
Gel electrophoresis: SDS-PAGE was performed using 6M urea and standard protocols. Each 
lane was loaded with 30 µl of eluted fractions and 1µl of the reaction mix. 
Electrophysiology 
 
Electrophysiological experiments were carried out as previously described (Szabò I. et al., 
2011; Teardo E., et al 2010). A Warner Instruments (Hamden) electrophysiological planar 
bilayer apparatus was used. Bilayers of approximately 150-200 pF capacity were prepared 
using azolectin in decane containing 1% chloroform (Sigma) across a 250 µM hole in a 
polystyrene cuvette. Azolectin was partially purified by precipitation with col acetone from a 
chloroform solution. The inside of the cuvette constituted the trans compartment. The 
standard experimental medium was 150mM KCl. The lipid membrane was built under 
symmetric ionic conditions and both chambers contained 3ml of solution. The contents of 
both chambers were stirred by magnetic bars when desired. Connections to the electrodes 
were provided by agar bridges. Purified proteins were added to the cis side. Control 
experiments with empty membrane or with detergents used for the purification showed no 
activity. All voltages reported are those of the cis chamber, zero being assigned by 
convention to the trans (grounded) side. Currents are considered as positive when carried by 
cations flowing from the cis to the trans compartments. A BC-525C unit and headstage were 
used to control parameters and amplify signals. Output was recorded with a 10kHz 
bandwidth on videotape using a Medical System PCM-2 interface. Data were acquired at 
2kHz, filtered at 500 Hz and analyzed offline using the pClamp program set (Axon 
Instruments). Conductance was determined by averaging the measured amplitudes of single 
channel events (n ≥ 50) at various applied voltages. 
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Crispr/Cas9 technology 
 
For generating mitoK-KO cell lines, two Cas9 guides targeting different regions of the human 
CCDC51 gene were designed (GCCCCTCCGAACCAGTACGT and TCATGAGAAGGAGCGCACAA) 
and cloned into the BsmBI site of the  LentiCrisprV2 plasmid, a kind gift of Feng Zhang 
(Addgene plasmid #52961). Lentiviral particles were produced by transfecting 293T cells with 
the transfer plasmids together with pRSV-Rev (Addgene #12253), pMDLg/pRRE (Addgene 
#12251) and pMD2.G (Addgene #12259) plasmids, kindly provided by Didier Trono. Three 
days after transfection, the supernatants were collected, centrifuged and cleared through 
0.45m cellulose acetate filters. Target cells were infected with viral particles and selected 
with puromycin for one week. Dilution cloning was performed to obtain different 
monoclonal cell populations that were screened and validated for CCDC51 gene ablation 
through Western blot.   
Statistical analysis of data 
 
Statistical data are presented as mean ± s.e.m, unless otherwise specified. Significance was 
calculated by Student’s t-test. 
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